"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,US,A,US 3972257 A,013-402-692-079-542,1976-08-03,1976,US 61323775 A,1975-09-15,US 61323775 A;;US 53230074 A,1974-12-12,Bar stock shear,"A hydraulic shear for bar stock including a die housing constructed so that the forces produced by the shearing operation are absorbed by interlocking joints. The structure assures that there are no welded or bolted joints in the die housing in a position to receive the stresses resulting from the shearing operation. The shear comprises a three bolster arrangement wherein a hydraulic cylinder is positioned between a first end bolster and a center bolster and fitted into recesses provided in such bolsters. The die housing is positioned between the center bolster and the other end bolster and similarly fitted into recesses provided in those bolsters. Top and bottom plates are recessed and interfitted over the die retainer end plates to provide an interlocking construction eliminating the need for bolts and welds in the die housing. Such arrangement not only provides a strong stable unit, but also allows efficient access to the dies, such as for die changes.",LAZAR JR JOHN DANIEL,LAZAR JR JOHN DANIEL,BEMCOR INC. A CORP. OF IN,https://lens.org/013-402-692-079-542,Granted Patent,yes,2,15,1,1,0,B23D15/14;;B23D23/00;;Y10T83/412;;Y10T83/8858;;Y10T83/9473;;Y10T83/8743;;Y10T83/412;;Y10T83/8858;;Y10T83/9473;;Y10T83/8743;;B23D23/00;;B23D15/14,B23D15/14;;B23D23/00,83/198,0,0,,,,EXPIRED
2,US,A1,US 2023/0329440 A1,041-855-331-378-288,2023-10-19,2023,US 202318210814 A,2023-06-16,US 202318210814 A;;US 202117505488 A;;US 202063104683 P,2020-10-23,MULTIPLE SITTING POSITION CHAIR,"A reconfigurable chair includes features that open up new sitting and resting positions for the user. The chair includes rotatable lateral side rests and a tilt adjustable back rest which when reconfigured, provide auxiliary resting platforms to support the body in different sitting and resting positions. The backrest may include a rotatable feature so that the backrest may be moved from an upright position to a flat position adding another level of support. A height adjustment mechanism may adjust the height of the backrest to add to the reconfigurability of the chair. Some embodiments include one or more gas pistons providing user-controlled adjustment of elements into any of an infinite number of user-controlled positions.",LOST LUGGAGE ID LTD,LAZAR DANIEL;;OLAWALE SAM ADEDAMOLA,,https://lens.org/041-855-331-378-288,Patent Application,yes,0,0,1,3,0,A47C9/002;;A47C1/024;;A47C1/026;;A47C1/0244;;A47C7/446;;A47C7/402;;A47C7/541,A47C7/40;;A47C7/44;;A47C7/54,,0,0,,,,PENDING
3,US,B2,US 11717089 B2,020-478-296-953-650,2023-08-08,2023,US 202117505488 A,2021-10-19,US 202117505488 A;;US 202063104683 P,2020-10-23,Multiple sitting position chair,"A reconfigurable chair includes features that open up new sitting and resting positions for the user. The chair includes rotatable lateral side rests and a tilt adjustable back rest which when reconfigured, provide auxiliary resting platforms to support the body in different sitting and resting positions. The backrest may include a rotatable feature so that the backrest may be moved from an upright position to a flat position adding another level of support. A height adjustment mechanism may adjust the height of the backrest to add to the reconfigurability of the chair.",LOST LUGGAGE ID LTD,LAZAR DANIEL;;OLAWALE SAM ADEDAMOLA,LOST LUGGAGE ID LIMITED (2023-06-02),https://lens.org/020-478-296-953-650,Granted Patent,yes,34,0,2,3,0,A47C13/00;;A47C9/002;;A47C7/024;;A47C7/40;;A47C7/405;;A47C7/407;;A47C13/00;;A47C7/14;;A47C1/0308;;A47C7/407;;A47C7/44;;A47C1/03;;A47C7/024;;A47C1/0244;;A47C7/48;;A47C7/54;;A47C7/541;;A47C7/543,A47C1/024;;A47C1/03;;A47C7/02;;A47C7/14;;A47C7/40;;A47C7/44;;A47C7/48;;A47C7/54;;A47C13/00,,0,0,,,,ACTIVE
4,US,A1,US 2022/0125205 A1,154-983-902-141-908,2022-04-28,2022,US 202117505488 A,2021-10-19,US 202117505488 A;;US 202063104683 P,2020-10-23,MULTIPLE SITTING POSITION CHAIR,"A reconfigurable chair includes features that open up new sitting and resting positions for the user. The chair includes rotatable lateral side rests and a tilt adjustable back rest which when reconfigured, provide auxiliary resting platforms to support the body in different sitting and resting positions. The backrest may include a rotatable feature so that the backrest may be moved from an upright position to a flat position adding another level of support. A height adjustment mechanism may adjust the height of the backrest to add to the reconfigurability of the chair.",LOST LUGGAGE ID LTD,LAZAR DANIEL;;OLAWALE SAM ADEDAMOLA,LOST LUGGAGE ID LIMITED (2023-06-02),https://lens.org/154-983-902-141-908,Patent Application,yes,34,0,2,3,0,A47C13/00;;A47C9/002;;A47C7/024;;A47C7/40;;A47C7/405;;A47C7/407;;A47C13/00;;A47C7/14;;A47C1/0308;;A47C7/407;;A47C7/44;;A47C1/03;;A47C7/024;;A47C1/0244;;A47C7/48;;A47C7/54;;A47C7/541;;A47C7/543,A47C7/14;;A47C13/00,,0,0,,,,ACTIVE
5,CH,A,CH 501887 A,104-910-099-749-488,1971-01-15,1971,CH 338769 A,1969-03-06,US 71131568 A,1968-03-07,"Verfahren und Vorrichtung zur Behandlung von kleinteiligem, wärmeempfindlichem Material mit einem Gas",,FARKAS DANIEL FREDERICK;;LAZAR MELVIN E,DANIEL FREDERICK FARKAS;;MELVIN E LAZAR,,https://lens.org/104-910-099-749-488,Granted Patent,no,0,1,9,9,0,A23L3/50;;A23L3/50;;A23L7/183;;A23L7/183;;B01J8/38;;B01J8/38;;D06C7/00;;D06C7/00;;D06C2700/09;;D06C2700/09;;F26B7/007;;F26B7/007,A23L1/18;;A23L3/50;;B01J8/38;;D06C7/00;;F26B7/00,,0,0,,,,EXPIRED
6,US,A,US 3500552 A,149-271-789-943-303,1970-03-17,1970,US 3500552D A,1968-03-07,US 71131568 A,1968-03-07,METHOD AND APPARATUS FOR DRYING FOODS,,US AGRICULTURE,FARKAS DANIEL F;;LAZAR MELVIN E,,https://lens.org/149-271-789-943-303,Granted Patent,no,2,13,9,9,0,A23L3/50;;A23L3/50;;A23L7/183;;A23L7/183;;B01J8/38;;B01J8/38;;D06C7/00;;D06C7/00;;D06C2700/09;;D06C2700/09;;F26B7/007;;F26B7/007,A23L1/18;;A23L3/50;;B01J8/38;;D06C7/00;;F26B7/00,34/8,0,0,,,,EXPIRED
7,CA,A,CA 899701 A,102-730-855-211-907,1972-05-09,1972,CA 899701D A,,CA 899701T A,,METHOD AND APPARATUS FOR DRYING FOODS,,FARKAS DANIEL F;;LAZAR MELVIN E,FARKAS DANIEL F;;LAZAR MELVIN E,,https://lens.org/102-730-855-211-907,Granted Patent,no,0,0,1,1,0,,A23L3/50;;A23L7/174;;B01J8/38;;D06C7/00;;F26B7/00,,0,0,,,,EXPIRED
8,DE,A1,DE 1910744 A1,005-296-194-318-698,1970-01-08,1970,DE 1910744 A,1969-03-03,US 72962668 A,1968-05-16,Vorrichtung zur Behandlung von Nahrungs- und Genussmitteln,,FARKAS DANIEL FREDERICK,FREDERICK FARKAS DANIEL;;E LAZAR MELVIN,,https://lens.org/005-296-194-318-698,Patent Application,no,0,1,9,9,0,A23L3/001;;A23L3/06;;A23L3/185;;A23L3/225;;A23L3/225;;A23L3/001;;A23L3/185;;A23L3/06,A23L3/16;;A23L3/00;;A23L3/06;;A23L3/18;;A23L3/22,,0,0,,,,EXPIRED
9,DE,A1,DE 1910003 A1,182-973-129-669-970,1969-10-02,1969,DE 1910003 A,1969-02-27,US 71131568 A,1968-03-07,"Verfahren und Vorrichtung zur Wirbelschichtbehandlung,insbesondere -trocknung von aus losen Teilchen oder Stuecken bestehenden Materialien",,FARKAS DANIEL FREDERICK;;LAZAR MELVIN E,FREDERICK FARKAS DANIEL;;E LAZAR MELVIN,,https://lens.org/182-973-129-669-970,Patent Application,no,0,4,9,9,0,A23L3/50;;A23L3/50;;A23L7/183;;A23L7/183;;B01J8/38;;B01J8/38;;D06C7/00;;D06C7/00;;D06C2700/09;;D06C2700/09;;F26B7/007;;F26B7/007,A23L1/18;;A23L3/50;;B01J8/38;;D06C7/00;;F26B7/00,,0,0,,,,EXPIRED
10,US,A,US 3489074 A,028-482-179-011-181,1970-01-13,1970,US 3489074D A,1968-05-16,US 72962668 A,1968-05-16,FOOD-TREATING DEVICE WITH HELICAL PUMPING SYSTEM,,US AGRICULTURE,FARKAS DANIEL F;;LAZAR MELVIN E,,https://lens.org/028-482-179-011-181,Granted Patent,no,7,14,9,9,0,A23L3/001;;A23L3/06;;A23L3/185;;A23L3/225;;A23L3/225;;A23L3/001;;A23L3/185;;A23L3/06,A23L3/16;;A23L3/00;;A23L3/06;;A23L3/18;;A23L3/22,99/249,0,0,,,,EXPIRED
11,CA,A,CA 915506 A,196-303-746-483-114,1972-11-28,1972,CA 915506D A,,CA 915506T A,,FOOD TREATING DEVICE WITH HELICAL PUMPING SYSTEM,,FARKAS DANIEL F,FARKAS DANIEL F;;LAZAR MELVIN E,,https://lens.org/196-303-746-483-114,Granted Patent,no,0,1,1,1,0,,A23L3/00;;A23L3/06;;A23L3/18;;A23L3/22,,0,0,,,,EXPIRED
12,CH,A,CH 498590 A,013-420-645-280-162,1970-11-15,1970,CH 662269 A,1969-04-29,US 72962668 A,1968-05-16,Vorrichtung zur Behandlung von Nahrungs- und Genussmitteln sowie anderen Gütern,,FARKAS DANIEL FREDERICK,DANIEL FREDERICK FARKAS;;MELVIN E LAZAR,,https://lens.org/013-420-645-280-162,Granted Patent,no,0,0,9,9,0,A23L3/001;;A23L3/06;;A23L3/185;;A23L3/225;;A23L3/225;;A23L3/001;;A23L3/185;;A23L3/06,A23L3/16;;A23L3/00;;A23L3/06;;A23L3/18;;A23L3/22,,0,0,,,,EXPIRED
13,GB,A,GB 1235235 A,098-457-836-365-188,1971-06-09,1971,GB 1100869 A,1969-02-28,US 71131568 A,1968-03-07,TREATING PARTICULATE MATERIALS WITH A GAS,"1,235,235. Treating food; treating seeds with gases. D. F. FARKAS and M. E. LAZAR. 28 Feb., 1969 [7 March, 1968], No. 11008/69. Headings A2D and A2Q. [Also in Division F4] Particulate material is treated with a gas by introducing it into perforated basket 5, rotating the basket to apply centrifugal force to the material, and directing a stream of gas via inlet 2 through the mass of material in a direction counter to the centrifugal force, the velocity of the gas stream being sufficiently high to cause the individual particles actively to tumble about within the mass, but not so high as to eject particles from the mass before they have undergone a predetermined treatment. The velocity of the gas stream may be sufficiently high to fluidize the mass of material. The process is applicable to drying and dehydrating foods, e.g. peas, beans, other vegetables, fruit, meat, yeast, bones, feathers, wool or cotton, puffing wheat, rice, corn, potatoes and fruit, roasting coffee, cooking or blanching foods, cooling and freezing foods, and reacting solids with gases. Smoke or sulphur dioxide may be added to the chamber. In a continuous process, e.g. drying, the material is introduced at a desired rate by compressed air through inlet 15 and is only ejected into chamber 17 when its density has been sufficiently reduced by drying.",FARKAS DANIEL FREDERICK;;LAZAR MELVIN E,FARKAS DANIEL FREDERICK;;LAZAR MELVIN E,,https://lens.org/098-457-836-365-188,Granted Patent,no,0,3,9,9,0,A23L3/50;;A23L3/50;;A23L7/183;;A23L7/183;;B01J8/38;;B01J8/38;;D06C7/00;;D06C7/00;;D06C2700/09;;D06C2700/09;;F26B7/007;;F26B7/007,A23L1/18;;A23L3/50;;B01J8/38;;D06C7/00;;F26B7/00,,0,0,,,,EXPIRED
14,CN,A,CN 103575967 A,004-771-707-322-806,2014-02-12,2014,CN 201310346470 A,2013-08-09,US 201213570319 A,2012-08-09,Method and system for isolating voltage sensor errors from contactor errors in an electrical system,"A method for isolating voltage sensor errors from contactor errors in an electrical system includes measuring a voltage between ground and a voltage bus rail when a contactor is open, and comparing the measured voltage with a first threshold voltage corresponding to a calibrated voltage reading that is expected when the contactor is closed. A first diagnostic code is recorded with a stuck-in-range status for the sensor when the measured voltage is greater than 0 and less than the first threshold voltage. A second diagnostic code is recorded with a stuck-closed status for the contactor when the measured voltage is equal to the first threshold voltage. The measured voltage may be compared with a second threshold voltage that exceeds the first threshold voltage, with a third diagnostic code recorded with a shorted value for the sensor when the measured voltage exceeds the first threshold voltage or is less than 0.",GM GLOBAL TECH OPERATIONS INC,LAZAR II WALTER M;;GRENN DANIEL P,,https://lens.org/004-771-707-322-806,Patent Application,no,6,12,6,6,0,G01R35/00;;B60L3/04;;G01R31/52;;G01R35/00;;B60L3/04;;G01R31/52,G01R19/165;;G01R31/00,,0,0,,,,ACTIVE
15,DE,A1,DE 102013215467 A1,178-548-325-568-665,2014-02-13,2014,DE 102013215467 A,2013-08-06,US 201213570319 A,2012-08-09,VERFAHREN UND SYSTEM ZUM ISOLIEREN VON FEHLERN BEI SPANNUNGSSENSOREN UND SCHÜTZEN IN EINEM ELEKTRISCHEN SYSTEM,"Ein Verfahren zum Isolieren von Spannungssensorfehlern von Schützfehlern in einem elektrischen System umfasst, dass eine Spannung zwischen Masse und einer Spannungsbusstromschiene gemessen wird, wenn ein Schütz geöffnet ist, und die gemessene Spannung mit einer ersten Schwellenwertspannung verglichen wird, die einem kalibrierten Spannungslesewert entspricht, der erwartet wird, wenn das Schütz geschlossen ist. Ein erster Diagnosecode mit einem Status mit Festsitzen im Messbereich für den Sensor wird aufgezeichnet, wenn die gemessene Spannung größer als 0 und kleiner als die erste Schwellenwertspannung ist. Ein zweiter Diagnosecode mit einem Status mit Festsitzen im geschlossenen Zustand für das Schütz wird aufgezeichnet, wenn die gemessene Spannung gleich der ersten Schwellenwertspannung ist. Die gemessene Spannung kann mit einer zweiten Schwellenwertspannung verglichen werden, welche die erste Schwellenwertspannung überschreitet, wobei ein dritter Diagnosecode mit einem Kurzschlusswert für den Sensor aufgezeichnet wird, wenn die gemessene Spannung die erste Schwellenwertspannung überschreitet oder kleiner als 0 ist.",GM GLOBAL TECH OPERATIONS INC,LAZAR II WALTER M;;GRENN DANIEL P,,https://lens.org/178-548-325-568-665,Patent Application,no,0,1,6,6,0,G01R35/00;;B60L3/04;;G01R31/52;;G01R35/00;;B60L3/04;;G01R31/52,G01R31/00;;G01R19/165;;G01R31/02,,0,0,,,,ACTIVE
16,DE,B4,DE 102013215467 B4,103-980-496-925-251,2022-12-01,2022,DE 102013215467 A,2013-08-06,US 201213570319 A,2012-08-09,VERFAHREN UND SYSTEM ZUM ISOLIEREN VON FEHLERN BEI SPANNUNGSSENSOREN UND SCHÜTZEN IN EINEM ELEKTRISCHEN SYSTEM,"System, das umfasst:eine Spannungsquelle (16);einen Spannungsbus (20);ein Schütz (40);eine elektrische Last, die mit Hilfe des Schützes (40) über den Spannungsbus (20) selektiv mit der Spannungsquelle (16) verbunden und von dieser getrennt wird;einen Spannungssensor (34), der ausgestaltet ist, um eine Spannung zwischen elektrischer Masse (26) und einer leitfähigen Stromschiene des Spannungsbusses (20) zu messen; undeinen Controller (50) in Kommunikation mit dem Spannungssensor (34), der eine konkrete nichtflüchtige Speichervorrichtung (54), in der Anweisungen zum Isolieren eines elektrischen Fehlers im System aufgezeichnet sind, und einen Prozessor (52) enthält, der die Anweisungen ausführt, wobei die Ausführung der Anweisungen durch den Prozessor (52) bewirkt, dass der Controller (50):die gemessene Spannung vom Spannungssensor (34) empfängt, wenn das Schütz (40) geöffnet ist;die empfangene gemessene Spannung mit einer ersten Schwellenwertspannung vergleicht, wobei die erste Schwellenwertspannung einem kalibrierten Spannungslesewert entspricht, der erwartet wird, wenn das Schütz (40) geschlossen ist;einen ersten Diagnosecode mit einem Fehlerstatus mit Festsitzen im Messbereich für den Spannungssensor (34) aufzeichnet, wenn die empfangene gemessene Spannung größer als 0 und kleiner als die erste Schwellenwertspannung ist; undeinen zweiten Diagnosecode mit einem Status mit Festsitzen im geschlossenen Zustand für das Schütz (40) aufzeichnet, wenn die empfangene gemessene Spannung gleich der ersten Schwellenwertspannung ist.",GM GLOBAL TECH OPERATIONS LLC,LAZAR II WALTER M;;GRENN DANIEL P,,https://lens.org/103-980-496-925-251,Granted Patent,no,5,0,6,6,0,G01R35/00;;B60L3/04;;G01R31/52;;G01R35/00;;B60L3/04;;G01R31/52,G01R31/00;;G01R19/165;;G01R31/327;;G01R31/50,,0,0,,,,ACTIVE
17,US,B2,US 9217765 B2,006-099-634-841-444,2015-12-22,2015,US 201213570319 A,2012-08-09,US 201213570319 A,2012-08-09,Method and system for isolating voltage sensor and contactor faults in an electrical system,"A method for isolating voltage sensor errors from contactor errors in an electrical system includes measuring a voltage between ground and a voltage bus rail when a contactor is open, and comparing the measured voltage to a first threshold voltage corresponding to a calibrated voltage reading that is expected when the contactor is closed. A first diagnostic code is recorded with a stuck-in-range status for the sensor when the measured voltage is greater than 0 and less than the first threshold voltage. A second diagnostic code is recorded with a stuck-closed status for the contactor when the measured voltage is equal to the first threshold voltage. The measured voltage may be compared to a second threshold voltage that exceeds the first threshold voltage, with a third diagnostic code recorded with a shorted value for the sensor when the measured voltage exceeds the first threshold voltage or is less than 0.",LAZAR II WALTER M;;GRENN DANIEL P;;GM GLOBAL TECH OPERATIONS INC,LAZAR II WALTER M;;GRENN DANIEL P,GM GLOBAL TECHNOLOGY OPERATIONS LLC (2012-08-06),https://lens.org/006-099-634-841-444,Granted Patent,yes,8,6,6,6,0,G01R35/00;;B60L3/04;;G01R31/52;;G01R35/00;;B60L3/04;;G01R31/52,B60L3/04;;G01R31/02;;G01R35/00,,0,0,,,,ACTIVE
18,US,A1,US 2014/0046534 A1,089-407-418-086-053,2014-02-13,2014,US 201213570319 A,2012-08-09,US 201213570319 A,2012-08-09,METHOD AND SYSTEM FOR ISOLATING VOLTAGE SENSOR AND CONTACTOR FAULTS IN AN ELECTRICAL SYSTEM,"A method for isolating voltage sensor errors from contactor errors in an electrical system includes measuring a voltage between ground and a voltage bus rail when a contactor is open, and comparing the measured voltage to a first threshold voltage corresponding to a calibrated voltage reading that is expected when the contactor is closed. A first diagnostic code is recorded with a stuck-in-range status for the sensor when the measured voltage is greater than 0 and less than the first threshold voltage. A second diagnostic code is recorded with a stuck-closed status for the contactor when the measured voltage is equal to the first threshold voltage. The measured voltage may be compared to a second threshold voltage that exceeds the first threshold voltage, with a third diagnostic code recorded with a shorted value for the sensor when the measured voltage exceeds the first threshold voltage or is less than 0.",LAZAR II WALTER M;;GRENN DANIEL P;;GM GLOBAL TECH OPERATIONS INC,LAZAR II WALTER M;;GRENN DANIEL P,GM GLOBAL TECHNOLOGY OPERATIONS LLC (2012-08-06),https://lens.org/089-407-418-086-053,Patent Application,yes,8,18,6,6,0,G01R35/00;;B60L3/04;;G01R31/52;;G01R35/00;;B60L3/04;;G01R31/52,G01R31/14;;B60L11/18;;G06F19/00,701/33.9;;324/509;;702/58,0,0,,,,ACTIVE
19,WO,A1,WO 2019/079819 A1,060-816-079-401-948,2019-04-25,2019,US 2018/0056943 W,2018-10-22,US 201762575307 P,2017-10-20,COMPOSITION AND METHOD FOR ACTIVATING LATENT HUMAN IMMUNODEFICIENCY VIRUS (HIV),"Provided are compositions and methods for activating latent Human Immunodeficiency Virus (HIV). The compositions and methods may utilize a recombinant peptide that has a DNA binding zinc finger domain specific to the HIV long terminal repeat (LTR) sequence. The recombinant peptide may also have a transcription factor (e.g. a transcription activator) that is conjugated to the zinc finger domain. Also provided are methods of treating HIV in a subject in need of the treatment. The method may involve activation of latent HIV in cells of the subject and selectively removing such cells from the subject, providing complete and effective treatment of HIV.",HOPE CITY,MORRIS KEVIN;;WEINBERG MARC;;SCOTT TRISTAN;;LAZAR DANIEL,,https://lens.org/060-816-079-401-948,Patent Application,yes,3,5,4,4,18,A61K38/00;;C07K14/4705;;C07K2319/09;;C07K2319/10;;C07K2319/24;;A61P31/18;;C07K16/10;;C07K14/00,A61K38/00;;A61K48/00;;C07H21/02;;C07H21/04;;C07K14/00;;C12N15/00,,4,4,069-505-009-938-554;;074-804-923-371-650;;078-168-540-374-660;;034-503-854-530-303,10.1002/pro.233;;19701937;;pmc2788277;;25144775;;pmc4140746;;10.1371/journal.pone.0104908;;26096782;;10.1016/j.febslet.2015.06.013;;24622733;;10.1038/gt.2014.21,"SAKKHACHORNPHOP ET AL.: ""Designed zinc finger protein interacting with the HIV-1 integrase recognition sequence at 2-LTR-circle junctions"", PROTEIN SCIENCE, vol. 18, no. 11, 21 August 2009 (2009-08-21) - November 2009 (2009-11-01), pages 2219 - 2230, XP055597774, ISSN: 0961-8368, DOI: 10.1002/pro.233;;BENJAMIN ET AL.: ""Mycobacterial and HIV Infections Up-Regulated Human Zinc Finger Protein 134, a Novel Positive Regulator of HIV-1 LTR Activity and Viral Propagation"", PLOS ONE, vol. 9, no. 8, 21 August 2014 (2014-08-21), pages e104908, XP055597777, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0104908;;NISHITSUJI ET AL.: ""ZNF10 inhibits HIV-1 LTR activity through interaction with NF-kB and Sp1 binding motifs"", FEBS LETT, vol. 589, no. 15, 19 June 2015 (2015-06-19) - 8 July 2015 (2015-07-08), pages 2019 - 2025, XP055597779, ISSN: 0014-5793, DOI: 10.1016/j.febslet.2015.06.013;;WANG ET AL.: ""Specific reactivation of latent HIV-1 with designer zinc-finger transcription factors targeting the HIV-1 5'-LTR promoter"", GENE THERAPY, vol. 21, no. 5, 13 March 2014 (2014-03-13) - May 2014 (2014-05-01), pages 490 - 495, XP055597780, ISSN: 0969-7128, DOI: 10.1038/gt.2014.21",PENDING
20,US,A1,US 2013/0151014 A1,030-449-321-914-689,2013-06-13,2013,US 201213431769 A,2012-03-27,US 201213431769 A;;US 201161569859 P,2011-12-13,"HEATING, VENTILATION AND AIR CONDITIONING SYSTEM USER INTERFACE HAVING MEMORY UPGRADE FEATURE AND METHOD OF OPERATION THEREOF","A user interface for use with an HVAC system, a method of providing service reminders on a single screen of a user interface of an HVAC system and an HVAC system incorporating the user interface or the method. In one embodiment, the user interface includes: (1) a display configured to provide information to a user, (2) a touchpad configured to accept input from the user, (3) a processor and memory coupled to the display and the touchpad and configured to drive the display and (4) at least one socket coupled to the processor and configured to receive a media card.",LAZAR STEVEN C;;VENDT STEPHEN J;;CASTILLO DANIEL,LAZAR STEVEN C;;VENDT STEPHEN J;;CASTILLO DANIEL,LENNOX INDUSTRIES INC (2012-03-27),https://lens.org/030-449-321-914-689,Patent Application,yes,6,0,3,28,0,F24F11/30;;F24F11/52;;F24F11/30;;F24F11/52,G05D23/00,700/276,0,0,,,,DISCONTINUED
21,US,A,US 4684277 A,185-089-041-406-617,1987-08-04,1987,US 45494783 A,1983-01-03,US 45494783 A;;US 21095380 A,1980-11-28,Apparatus for delaying printer bail closing,"An apparatus for delaying the closing of a printer paper bail so that paper positioned for the first line of printing at the top of the paper will advance in the paper path to a position where the paper bail can close on it. The apparatus mounts on a conventional paper bail assembly and has a sector cam which rotates to a position between its axis of rotation and the platen thereby restraining the closing of the paper bail. It is preferable that the sector cam contact the drive gear of the platen. When the platen rotates for feeding the paper through the paper path, frictional contact between the sector cam and the platen gear causes the sector cam to rotate to a position where the sector is no longer between its axis of rotation and the platen thereby permitting the paper bail which is under spring tension to close.",RAYTHEON CO,EDSTROM CARL W;;FEDELE DANIEL E;;LAZAR MARTIN,,https://lens.org/185-089-041-406-617,Granted Patent,yes,8,11,1,1,0,B41J11/36;;B41J13/20;;B41J13/20;;B41J11/36,B41J11/36;;B41J13/20,400/639.1;;400/624,1,0,,,"IBM Technical Disclosure Bulletin, Automatic Mechanical Paper Bail Closer , Roy et al, vol. 22, No. 6, Nov., 1979, pp. 2173 2174.",EXPIRED
22,TW,A,TW 201829873 A,120-604-426-758-379,2018-08-16,2018,TW 106121047 A,2017-06-23,US 201662356901 P,2016-06-30,Flexible fibrous surface-treating article with low formaldehyde off-gassing,"Various embodiments disclosed related to flexible fibrous surface-treating articles with low formaldehyde off-gassing. In various embodiments, the present invention provides a flexible fibrous surface-treating article including an open, lofty, nonwoven web including fibers. The flexible fibrous surface-treating article also includes a binder that coats the fibers of the nonwoven web. The binder includes a cured product of a curable composition including a latex and a crosslinker. The flexible fibrous surface-treating article heated to 65 DEG C in a closed space for 30 minutes emits less than about 6 micrograms of gaseous formaldehyde total per gram of the flexible fibrous surface-treating article.",3M INNOVATIVE PROPERTIES CO,ALTSHULER GORDON LAZAR;;LUND JESSE DANIEL;;TAI HUIWEN,,https://lens.org/120-604-426-758-379,Patent of Addition,no,0,0,4,4,0,C08C19/36;;C08K5/29;;D04H1/64;;D04H1/64;;D04H1/435;;D04H1/587;;D04H1/587;;D06M15/263;;D06M15/263;;D06M15/564;;D06M15/564;;D06M15/693;;D06M15/693;;D06M2101/32;;D06M2101/32,D06M15/00;;D04H1/58;;D04H1/64,,0,0,,,,PENDING
23,CA,A1,CA 2798403 A1,128-260-471-688-693,2013-06-13,2013,CA 2798403 A,2012-12-11,US 201161569859 P;;US 201213431769 A,2011-12-13,"HEATING, VENTILATION AND AIR CONDITIONING SYSTEM USER INTERFACE HAVING MEMORY UPGRADE FEATURE AND METHOD OF OPERATION THEREOF","A user interface for use with an HVAC system, a method of providing service reminders on a single screen of a user interface of an HVAC system and an HVAC system incorporating the user interface or the method. In one embodiment, the user interface includes: (1) a display configured to provide information to a user, (2) a touchpad configured to accept input from the user, (3) a processor and memory coupled to the display and the touchpad and configured to drive the display and (4) at least one socket coupled to the processor and configured to receive a media card.",LENNOX IND INC,LAZAR STEVEN C;;VENDT STEPHEN J;;CASTILLO DANIEL,,https://lens.org/128-260-471-688-693,Patent Application,no,0,0,3,28,0,F24F11/30;;F24F11/52;;F24F11/30;;F24F11/52,F24F11/00,,0,0,,,,DISCONTINUED
24,US,A,US 3449873 A,030-869-727-841-417,1969-06-17,1969,US 3449873D A,1965-07-14,US 47196065 A,1965-07-14,"PRECUT SHEET MATERIAL MOULDING ASSEMBLIES,TO BE SECURED TO ROOM WALLS,ALONG THE FLOOR OR DOOR OR WINDOW FRAMES",,DANIEL A DAMATO;;SHELDON LAZAR;;RICHARD B ZITTLER,DAMATO DANIEL A;;LAZAR SHELDON;;ZITTLER RICHARD B,,https://lens.org/030-869-727-841-417,Granted Patent,no,9,48,1,1,0,E04F19/0495;;E04F19/0495;;E04F19/0468;;E04F19/0468;;E04F2019/0413;;E04F2019/0413,E04F19/04,52/127,0,0,,,,EXPIRED
25,US,A,US 2437828 A,190-976-462-953-047,1948-03-16,1948,US 52230444 A,1944-02-14,US 52230444 A,1944-02-14,Alkylation of aromatic hydrocarbons with sulfuric acid catalyst avoiding sulfonationof product,,TIDE WATER ASSOCIATED OIL COMP,LYONS DANIEL J;;ARTHUR LAZAR;;INGRAHAM LLOYD L,,https://lens.org/190-976-462-953-047,Granted Patent,no,7,3,1,1,0,C07C2/70;;C07C2/70;;C07C2527/054;;C07C2527/054,C07C2/70,,0,0,,,,EXPIRED
26,DE,C3,DE 1910744 C3,001-857-350-563-065,1978-10-12,1978,DE 1910744 A,1969-03-03,US 72962668 A,1968-05-16,DE 1910744 C3,,"FARKAS, DANIEL FREDERICK, KENSINGTON, CALIF. (V.ST.A.)","FARKAS, DANIEL FREDERICK, KENSINGTON;;LAZAR, MELVIN E., OAKLAND",,https://lens.org/001-857-350-563-065,Granted Patent,no,0,1,9,9,0,A23L3/001;;A23L3/06;;A23L3/185;;A23L3/225;;A23L3/225;;A23L3/001;;A23L3/185;;A23L3/06,A23L3/16;;A23L3/00;;A23L3/06;;A23L3/18;;A23L3/22,,0,0,,,,EXPIRED
27,EP,A1,EP 2604937 A1,132-269-422-944-860,2013-06-19,2013,EP 12197016 A,2012-12-13,US 201161569859 P;;US 201213431769 A,2011-12-13,"Heating, ventilation and air conditioning system user interface having memory upgrade feature and method of operation thereof","A user interface for use with an HVAC system, a method of providing service reminders on a single screen of a user interface of an HVAC system and an HVAC system incorporating the user interface or the method. In one embodiment, the user interface includes: (1) a display configured to provide information to a user, (2) a processor and memory coupled to the display and configured to drive the display and (3) at least one socket coupled to the processor and configured to receive a media card.
",LENNOX IND INC,LAZAR STEVEN C;;CASTILLO DANIEL;;VENDT STEPHEN J,,https://lens.org/132-269-422-944-860,Patent Application,yes,5,0,3,28,0,F24F11/30;;F24F11/52;;F24F11/30;;F24F11/52,F24F11/00,,0,0,,,,DISCONTINUED
28,US,B2,US 7814708 B2,133-524-285-711-287,2010-10-19,2010,US 45407909 A,2009-05-12,US 45407909 A;;US 78806804 A;;US 45030003 P,2003-02-26,Portable riser apparatus having a lifting and locking assembly,"There is provided a portable riser having an operator actuated lifting assist assembly operatively coupled to a riser deck. In one aspect, there is a first pivot mechanism coupled to a first support leg and adapted to initiate upward movement of the portable riser from a collapsed position when a downward force is applied to the first support leg, and a second pivot mechanism coupled to a second support leg and adapted to continue the upward movement. The lifting assist assembly provides a lifting force that continues upward movement to an upright position where the portable riser in locked. There is included a riser unlocking means for unlocking the lifting assist assembly. The portable riser remains in the upright position until the riser unlocking means is operated and a collapsing force is applied to the portable riser sufficient to overcome the lifting force and enable collapsed of the portable riser.",MIDWEST FOLDING PRODUCTS,RIVERA JR JEREMIAS C;;LAZAR JOHN DANIEL;;SAMIKKANNU DOSS,NUDO PRODUCTS INC (2014-11-14),https://lens.org/133-524-285-711-287,Granted Patent,yes,44,3,3,3,0,E04H3/126;;E04H3/126,E04H3/28;;E04H3/30,52/10;;52/9;;52/7;;182/132,0,0,,,,EXPIRED
29,SG,A1,SG 178971 A1,088-145-534-742-384,2012-04-27,2012,SG 2012015137 A,2010-08-31,US 24003009 P;;US 87280710 A;;US 2010/0047345 W,2009-09-04,SYSTEM FOR VOLUME-WEIGHTED AVERAGE PRICE TRADING,"Systems, methods, and mediums storing programs for trading financial assets. The method can include receiving a first order specifying a first quantity of financial assets to be traded according to a volume-weighted average price for a trading session and executing the first order during the trading session through algorithmic or traditional trading of the first quantity of financial assets on an exchange. The method can also include creating a second order specifying the first quantity of financial assets to be traded according to a volume-weighted average price measured from a moment of cross to an end of the trading session and exposing the second order to a non-exchange crossing pool concurrently with the execution of the first order. The crossing pool can include multiple orders. The method can include continuously determining whether any of the plurality of orders in the crossing pool can be crossed with the second order.",TORA HOLDINGS INC,WINGERDEN GERRIT VAN;;LAZAR PAUL-DANIEL;;DUCKER JAMES KEITH,,https://lens.org/088-145-534-742-384,Patent Application,no,0,0,7,7,0,G06Q40/04;;G06Q40/06;;G06Q40/06;;G06Q40/04,,,0,0,,,,PENDING
30,US,A1,US 2011/0078065 A1,023-739-652-187-385,2011-03-31,2011,US 87280710 A,2010-08-31,US 87280710 A;;US 24003009 P,2009-09-04,SYSTEM FOR VOLUME-WEIGHTED AVERAGE PRICE TRADING,"Systems, methods, and mediums storing programs for trading financial assets. The method can include receiving a first order specifying a first quantity of financial assets to be traded according to a volume-weighted average price for a trading session and executing the first order during the trading session through algorithmic or traditional trading of the first quantity of financial assets on an exchange. The method can also include creating a second order specifying the first quantity of financial assets to be traded according to a volume-weighted average price measured from a moment of cross to an end of the trading session and exposing the second order to a non-exchange crossing pool concurrently with the execution of the first order. The crossing pool can include multiple orders. The method can include continuously determining whether any of the plurality of orders in the crossing pool can be crossed with the second order.",TORA HOLDINGS INC,WINGERDEN GERRIT VAN;;LAZAR PAUL-DANIEL;;DUCKER JAMES KEITH,TORA HOLDINGS INC (2010-11-09),https://lens.org/023-739-652-187-385,Patent Application,yes,10,9,7,7,0,G06Q40/04;;G06Q40/06;;G06Q40/06;;G06Q40/04,G06Q40/00,705/37,0,0,,,,DISCONTINUED
31,DE,A1,DE 102020215153 A1,185-142-790-466-991,2022-06-02,2022,DE 102020215153 A,2020-12-01,DE 102020215153 A,2020-12-01,Verfahren und Kamerasystem zum Erzeugen von Steuerdaten für einen Erfassungsvorgang einer medizinischen Bildgebungsvorrichtung abhängig von einer Bewegung eines Patienten sowie Anlage,"Die Erfindung betrifft ein Verfahren zum Erzeugen von Steuerdaten (8) für einen Erfassungsvorgang einer medizinischen Bildgebungsvorrichtung (5), insbesondere eines Magnetresonanztomographen, mit folgenden Schritten, um eine genauere Erfassung einer Bewegung eines Patienten während eines Erfassungsvorgangs eines medizinischen Abbildes zu ermöglichen:- Aufeinanderfolgendes Erfassen mehrerer Kamerabilder eines Patienten (10) mittels einer Kameraanordnung (3) während eines Erfassungsvorgangs eines medizinischen Abbildes des Patienten (10) mittels eines primären Erfassungsprinzips der medizinischen Bildgebungsvorrichtung (5),- Bestimmen von Konturen des Patienten (10) in den mehreren Kamerabildern, und- Erzeugen von Steuerdaten (8) für den Erfassungsvorgang des medizinischen Abbildes in Abhängigkeit von einer anhand der Konturen erkannten Bewegung des Patienten (10).",SIEMENS HEALTHCARE GMBH,KROEKER RANDALL;;LAZAR RAZVAN;;MEYER HEIKO;;SPLITTHOFF DANIEL NICOLAS,"SIEMENS HEALTHINEERS AG, DE (2024-02-28)",https://lens.org/185-142-790-466-991,Patent Application,no,0,0,1,1,0,A61B5/055;;A61B5/1079;;A61B5/1127;;A61B5/0035;;A61B5/015;;A61B5/0077;;A61B5/721,A61B5/055;;A61B5/103,,0,0,,,,PENDING
32,AU,A1,AU 2010/289617 A1,023-305-710-828-243,2012-03-22,2012,AU 2010/289617 A,2010-08-31,US 87280710 A;;US 24003009 P;;US 2010/0047345 W,2009-09-04,System for volume-weighted average price trading,"Systems, methods, and mediums storing programs for trading financial assets. The method can include receiving a first order specifying a first quantity of financial assets to be traded according to a volume-weighted average price for a trading session and executing the first order during the trading session through algorithmic or traditional trading of the first quantity of financial assets on an exchange. The method can also include creating a second order specifying the first quantity of financial assets to be traded according to a volume-weighted average price measured from a moment of cross to an end of the trading session and exposing the second order to a non-exchange crossing pool concurrently with the execution of the first order. The crossing pool can include multiple orders. The method can include continuously determining whether any of the plurality of orders in the crossing pool can be crossed with the second order.",TORA HOLDINGS INC,WINGERDEN GERRIT VAN;;LAZAR PAUL-DANIEL;;DUCKER JAMES KEITH,,https://lens.org/023-305-710-828-243,Patent Application,no,0,0,7,7,0,G06Q40/04;;G06Q40/06;;G06Q40/06;;G06Q40/04,G06Q40/00,,0,0,,,,DISCONTINUED
33,US,A1,US 2009/0249713 A1,048-869-488-812-400,2009-10-08,2009,US 45407909 A,2009-05-12,US 45407909 A;;US 78806804 A;;US 45030003 P,2003-02-26,Portable riser apparatus having a lifting and locking assembly,"There is provided a portable riser having an operator actuated lifting assist assembly operatively coupled to a riser deck. In one aspect, there is a first pivot mechanism coupled to a first support leg and adapted to initiate upward movement of the portable riser from a collapsed position when a downward force is applied to the first support leg, and a second pivot mechanism coupled to a second support leg and adapted to continue the upward movement. The lifting assist assembly provides a lifting force that continues upward movement to an upright position where the portable riser in locked. There is included a riser unlocking means for unlocking the lifting assist assembly. The portable riser remains in the upright position until the riser unlocking means is operated and a collapsing force is applied to the portable riser sufficient to overcome the lifting force and enable collapsed of the portable riser.",RIVERA JR JEREMIAS C;;LAZAR JOHN DANIEL;;SAMIKKANNU DOSS,RIVERA JR JEREMIAS C;;LAZAR JOHN DANIEL;;SAMIKKANNU DOSS,NUDO PRODUCTS INC (2014-11-14),https://lens.org/048-869-488-812-400,Patent Application,yes,42,2,3,3,0,E04H3/126;;E04H3/126,E04F11/06,52/183,0,0,,,,EXPIRED
34,US,B1,US 7546705 B1,187-839-545-348-564,2009-06-16,2009,US 78806804 A,2004-02-26,US 78806804 A;;US 45030003 P,2003-02-26,Portable riser apparatus having a lifting and locking assembly,"There is provided a portable riser having an operator actuated lifting assist assembly operatively coupled to a riser deck. In one aspect, there is a first pivot mechanism coupled to a first support leg and adapted to initiate upward movement of the portable riser from a collapsed position when a downward force is applied to the first support leg, and a second pivot mechanism coupled to a second support leg and adapted to continue the upward movement. The lifting assist assembly provides a lifting force that continues upward movement to an upright position where the portable riser in locked. There is included a riser unlocking means for unlocking the lifting assist assembly. The portable riser remains in the upright position until the riser unlocking means is operated and a collapsing force is applied to the portable riser sufficient to overcome the lifting force and enable collapsed of the portable riser.",MIDWEST FOLDING PRODUCTS,RIVERA JR JEREMIAS C;;LAZAR JOHN DANIEL;;SAMIKKANNU DOSS,MIDWEST FOLDING PRODUCTS (2004-02-26);;NUDO PRODUCTS INC (2014-11-14),https://lens.org/187-839-545-348-564,Granted Patent,yes,37,10,3,3,0,E04H3/126;;E04H3/126,E04H3/28;;E04H3/30,52/10;;52/9;;52/7;;182/132,0,0,,,,INACTIVE
35,WO,A1,WO 2011/028717 A1,165-404-381-361-074,2011-03-10,2011,US 2010/0047345 W,2010-08-31,US 87280710 A;;US 24003009 P,2009-09-04,SYSTEM FOR VOLUME-WEIGHTED AVERAGE PRICE TRADING,"Systems, methods, and mediums storing programs for trading financial assets. The method can include receiving a first order specifying a first quantity of financial assets to be traded according to a volume-weighted average price for a trading session and executing the first order during the trading session through algorithmic or traditional trading of the first quantity of financial assets on an exchange. The method can also include creating a second order specifying the first quantity of financial assets to be traded according to a volume-weighted average price measured from a moment of cross to an end of the trading session and exposing the second order to a non-exchange crossing pool concurrently with the execution of the first order. The crossing pool can include multiple orders. The method can include continuously determining whether any of the plurality of orders in the crossing pool can be crossed with the second order.",TORA HOLDINGS INC;;WINGERDEN GERRIT VAN;;LAZAR PAUL-DANIEL;;DUCKER JAMES KEITH,WINGERDEN GERRIT VAN;;LAZAR PAUL-DANIEL;;DUCKER JAMES KEITH,,https://lens.org/165-404-381-361-074,Patent Application,yes,6,0,7,7,0,G06Q40/04;;G06Q40/06;;G06Q40/06;;G06Q40/04,G06Q40/00,,0,0,,,,PENDING
36,US,A1,US 2005/0244892 A1,056-426-235-651-909,2005-11-03,2005,US 6880605 A,2005-02-28,US 6880605 A;;US 54879504 P,2004-02-27,Resistin as a marker and therapeutic target for cardiovascular disease,The risk or progression of cardiovascular disease and coronary artery disease is assessed in a mammalian subject by measuring the level or concentration of circulating serum resistin in a subject and comparing the measured level to resistin levels within a standardized or standard population. Methods of treating cardiovascular diseases and/or inflammatory disorders involve administering to a patient a composition that can reduce the circulating levels of resistin.,LAZAR MITCHELL A;;RADER DANIEL J;;REILLY MUREDACH P,LAZAR MITCHELL A;;RADER DANIEL J;;REILLY MUREDACH P,TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA THE (2005-08-08),https://lens.org/056-426-235-651-909,Patent Application,yes,12,10,2,2,6,A61P9/10;;G01N33/6893;;G01N33/6893;;G01N2800/042;;G01N2800/042;;G01N2800/32;;G01N2800/32,G01N33/53;;G01N33/68,435/7.1,0,0,,,,DISCONTINUED
37,US,A1,US 2011/0110924 A1,166-581-324-302-047,2011-05-12,2011,US 87430510 A,2010-09-02,US 87430510 A;;US 6880605 A;;US 54879504 P,2004-02-27,Resistin as a Marker and Therapeutic Target for Cardiovascular Disease,The risk or progression of cardiovascular disease and coronary artery disease is assessed in a mammalian subject by measuring the level or concentration of circulating serum resistin in a subject and comparing the measured level to resistin levels within a standardized or standard population. Methods of treating cardiovascular diseases and/or inflammatory disorders involve administering to a patient a composition that can reduce the circulating levels of resistin.,UNIV PENNSYLVANIA,LAZAR MITCHELL A;;RADER DANIEL J;;REILLY MUREDACH P,,https://lens.org/166-581-324-302-047,Patent Application,yes,13,3,2,2,6,A61P9/10;;G01N33/6893;;G01N33/6893;;G01N2800/042;;G01N2800/042;;G01N2800/32;;G01N2800/32,A61K39/395;;A61P9/10;;G01N33/53;;G01N33/566;;G01N33/68,424/130.1;;436/501,4,3,015-916-862-425-77X;;005-260-147-794-38X;;000-927-935-062-359,10.1647/1082-6742(2002)016[0101:pvssdi]2.0.co;2;;12551861;;10.1161/01.cir.0000055014.62083.05;;10.1210/jc.2003-030898;;14671216,"Hrubec et al. ""Plasma Versus Serum: Specific Differences in Biochemical Analyte Values"" Journal of Avian Medicine and Surgery 16(2):101-105, 2002;;Ridker et al. ""C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events"" Circulation. 2003;107:391-397;;McTernan et al. ""Resistin and Type 2 Diabetes: Regulation of Resistin Expression by Insulin and Rosiglitazone and the Effects of Recombinant Resistin on Lipid and Glucose Metabolism in Human Differentiated Adipocytes"" The Journal of Clinical Endocrinology & Metabolism 88(12):6098-6106;;Reilly et al. ""Resistin is an inflammatory marker of atherosclerosis in humans"" Circulation, (OCT 26 2004) Vol. 110, No. 17, Suppl. S, pp. 743. Meeting Info.: 77th Scientific Meeting of the American-Heart-Association. New Orleans, LA, USA. November 07 -10, 2004. Amer Heart Assoc.",DISCONTINUED
38,EP,A1,EP 2473961 A1,067-772-827-024-010,2012-07-11,2012,EP 10814368 A,2010-08-31,US 87280710 A;;US 24003009 P;;US 2010/0047345 W,2009-09-04,SYSTEM FOR VOLUME-WEIGHTED AVERAGE PRICE TRADING,,TORA HOLDINGS INC,WINGERDEN GERRIT VAN;;LAZAR PAUL-DANIEL;;DUCKER JAMES KEITH,,https://lens.org/067-772-827-024-010,Patent Application,yes,0,0,7,7,0,G06Q40/04;;G06Q40/06;;G06Q40/06;;G06Q40/04,G06Q40/04;;G06Q40/06,,0,0,,,,DISCONTINUED
39,EP,A4,EP 2473961 A4,078-902-833-939-817,2013-08-28,2013,EP 10814368 A,2010-08-31,US 87280710 A;;US 24003009 P;;US 2010/0047345 W,2009-09-04,SYSTEM FOR VOLUME-WEIGHTED AVERAGE PRICE TRADING,,TORA HOLDINGS INC,WINGERDEN GERRIT VAN;;LAZAR PAUL-DANIEL;;DUCKER JAMES KEITH,,https://lens.org/078-902-833-939-817,Search Report,no,0,0,7,7,0,G06Q40/04;;G06Q40/06;;G06Q40/06;;G06Q40/04,G06Q40/04;;G06Q40/06,,1,0,,,No further relevant documents disclosed,DISCONTINUED
40,AU,A1,AU 2012/209329 A1,017-744-976-990-579,2013-09-12,2013,AU 2012/209329 A,2012-01-23,US 201161435721 P;;US 201161435724 P;;US 201161435704 P;;US 2012/0022248 W,2011-01-24,Methods for obtaining single cells and applications of single cell omics,"The present application provides methods for obtaining single cells from a sample. Methods for isolating and analyzing molecular features obtained from a single cell are also disclosed herein. For example, individual circulating tumor cells (CTCs) from a sample such as a patient's blood sample can be identified and obtained using methods disclosed herein, and picked for further analysis.",EPIC SCIENCES INC,YANG XING;;NELSON DAVID M;;KUHN PETER;;LAZAR DANIEL CHESNAYE,,https://lens.org/017-744-976-990-579,Patent Application,no,0,0,7,7,0,G01N33/56966;;G01N33/574;;G01N33/574;;G01N33/56966;;C12Q1/6886;;G01N33/57426,G01N33/574,,0,0,,,,DISCONTINUED
41,AU,A1,AU 2016/228165 A1,138-782-970-587-740,2016-09-29,2016,AU 2016/228165 A,2016-09-13,AU 2016/228165 A;;AU 2012/209329 A;;US 201161435704 P;;US 201161435724 P;;US 201161435721 P,2011-01-24,Methods for obtaining single cells and applications of single cell omics,"The present application provides methods for obtaining single cells from a sample. Methods for isolating and analyzing molecular features obtained from a single cell are also disclosed herein. For example, individual circulating tumor cells (CTCs) 5 from a sample such as a patient's blood sample can be identified and obtained using methods disclosed herein, and picked for further analysis.",EPIC SCIENCES INC,YANG XING;;NELSON DAVID M;;KUHN PETER;;LAZAR DANIEL CHESNAYE,,https://lens.org/138-782-970-587-740,Patent Application,no,0,0,7,7,0,G01N33/56966;;G01N33/574;;G01N33/574;;G01N33/56966;;C12Q1/6886;;G01N33/57426,G01N33/574,,0,0,,,,DISCONTINUED
42,DE,A1,DE 102019216139 A1,180-982-826-475-401,2021-03-25,2021,DE 102019216139 A,2019-10-21,EP 19465566 A,2019-09-25,"Verfahren zum Betreiben eines Treiberschaltkreises für einen Elektromotor, Treiberschaltkreis, Motoranordnung und Speichermedium","Die Erfindung betrifft ein Verfahren zum Betreiben einer Treiberschaltung für einen Elektromotor, wobei im Fall eines Fehlerzustands Steuerungsvektoren modifiziert und entsprechend modifizierte Steuerungsvektoren für den Weiterbetrieb des Elektromotors verwendet werden. Die Erfindung betrifft des Weiteren einen zugehörigen Treiberschaltkreis, eine zugehörige Motoranordnung sowie ein zugehöriges Speichermedium.",CONTINENTAL TEVES AG & CO OHG,IRIMIA NICOLAE DANIEL;;LUCHIAN MARIAN;;LAZAR IOAN FLORIN;;IPATIOV ALEXANDRU,"CONTINENTAL AUTOMOTIVE TECHNOLOGIES GMBH, DE (2024-02-21)",https://lens.org/180-982-826-475-401,Patent Application,no,6,0,1,1,0,H02P6/12;;H02P25/22;;H02P2207/05,H02P25/22,,0,0,,,,PENDING
43,AU,A1,AU 2021/227966 A1,163-239-893-348-923,2022-09-22,2022,AU 2021/227966 A,2021-02-26,US 202062981907 P;;US 2021/0019942 W,2020-02-26,Small molecule inhibitors of SLC15A4 with anti-inflammatory activity,"Disclosed are small molecule inhibitors of SLC15A4, and methods of using them to treat pDC-mediated diseases and conditions.",SCRIPPS RESEARCH INST,LAZAR DANIEL;;JADHAV APPASO;;PARKER CHRISTOPHER GEORGE;;TEIJARO JOHN ROSS,,https://lens.org/163-239-893-348-923,Patent Application,no,0,0,8,8,0,C07D471/04;;C07D235/30;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;A61P29/00;;C07D413/14;;C07D403/12;;A61K31/4184;;A61K31/428;;A61K31/4725;;A61K31/437;;A61P25/00;;A61P29/00;;C07D417/12;;C07D401/12;;C07D471/04;;C07D235/30;;C07D403/14;;C07D405/12;;C07D209/08;;C07D209/86;;C07D235/30;;C07D401/12;;C07D401/14;;C07D403/06;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D471/04,C07D235/30;;A61K31/4168;;A61P29/00;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D413/14;;C07D471/04,,0,0,,,,PENDING
44,US,B2,US 11618780 B2,169-611-304-458-400,2023-04-04,2023,US 201816756632 A,2018-10-22,US 201816756632 A;;US 201762575307 P;;US 2018/0056943 W,2017-10-20,Composition and method for activating latent human immunodeficiency virus (HIV),"Provided are compositions and methods for activating latent Human Immunodeficiency Virus (HIV). The compositions and methods may utilize a recombinant peptide that has a DNA binding zinc finger domain specific to the HIV long terminal repeat (LTR) sequence. The recombinant peptide may also have a transcription factor (e.g. a transcription activator) that is conjugated to the zinc finger domain. Also provided are methods of treating HIV in a subject in need of the treatment. The method may involve activation of latent HIV in cells of the subject and selectively removing such cells from the subject, providing complete and effective treatment of HIV.",HOPE CITY,MORRIS KEVIN V;;WEINBERG MARC S;;SCOTT TRISTAN;;LAZAR DANIEL,CITY OF HOPE (2017-11-08),https://lens.org/169-611-304-458-400,Granted Patent,yes,10,0,4,4,18,A61K38/00;;C07K14/4705;;C07K2319/09;;C07K2319/10;;C07K2319/24;;A61P31/18;;C07K16/10;;C07K14/00,C07K14/00;;C07K16/10,,27,23,099-167-300-017-549;;056-201-471-905-934;;028-862-168-091-90X;;111-183-092-806-684;;074-804-923-371-650;;037-984-500-227-226;;002-168-381-924-022;;034-354-996-309-78X;;025-660-906-976-925;;023-910-788-928-012;;023-907-179-348-058;;027-154-613-424-570;;019-779-601-634-917;;015-522-838-077-793;;032-728-154-591-070;;099-168-892-040-738;;092-760-851-706-263;;085-764-009-624-439;;062-833-010-361-260;;053-917-787-642-186;;018-481-020-492-772;;069-505-009-938-554;;034-503-854-530-303,8860685;;10.3109/02652049609026017;;2231712;;10.1006/jmbi.1990.9999;;10.1016/s0022-2836(05)80360-2;;10.1093/nar/25.17.3389;;9254694;;pmc146917;;26727042;;10.1038/mt.2015.236;;pmc4786922;;25144775;;pmc4140746;;10.1371/journal.pone.0104908;;7764467;;10.1016/0958-1669(93)90052-x;;8527843;;10.1016/0958-1669(95)80115-4;;10.1111/j.2042-7158.1997.tb06090.x;;9255709;;11402295;;10.1038/sj.gt.3301383;;7667190;;10.1023/a:1016209020160;;pmc50453;;1438297;;10.1073/pnas.89.22.10915;;10729149;;10.1128/jvi.74.8.3740-3751.2000;;pmc111883;;pmc46825;;8390686;;10.1073/pnas.90.12.5873;;pmc236888;;10.1128/jvi.68.6.3830-3840.1994;;8189520;;10.1016/0022-2836(70)90057-4;;5420325;;10.1093/ajhp/46.8.1576;;2672806;;6307823;;10.1016/0378-1119(83)90107-5;;10.1073/pnas.85.8.2444;;pmc280013;;3162770;;17264857;;10.1038/nmeth0207-119;;8924427;;10.1163/156856295x00526;;26581162;;10.1038/mt.2015.202;;pmc4786915;;10.1002/pro.233;;19701937;;pmc2788277;;24622733;;10.1038/gt.2014.21,"Al-Muhammed, J. et al. (May-Jun. 1996). “In-vivo studies on dexamethasone sodium phosphate liposomes,” J Microencapsul 13(3):293-306.;;Altschul, S.F. et al. (Oct. 5, 1990). “Basic local alignment search tool,” J Mol Biol 215(3):403-410.;;Altschul, S.F. et al. (Sep. 1, 1997). “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Research 25(17):3389-3402.;;Bailus B.J. et al. (Mar. 2016, e-published Jan. 4, 2016). “Protein Delivery of an Artificial Transcription Factor Restores Widespread Ube3a Expression in an Angelman Syndrome Mouse Brain,” Mol Ther. 24(3):548-555.;;Benjamin, R. et al. (Aug. 21, 2014). “Mycobacterial and HIV Infections Up-Regulated Human Zinc Finger Protein 134, a Novel Positive Regulator of HIV-1 LTR Activity and Viral Propagation,” PLoS One 9(8):e104908.;;Clarke, A.R. (Dec. 1993). “Transgenic Approaches to Cancer Biology,” Curr Opin Biotechnol 4(6):699-704.;;Chonn, A. et al. (Dec. 1995). “Recent advances in liposomal drug-delivery systems,” Curr Opin Biotechnol 6(6):698-708.;;Eyles, J.E. et al. (Jul. 1997). “Oral delivery and fate of poly(lactic acid) microsphere-encapsulated interferon in rats,” J. Pharm. Pharmacol. 49(7):669-674.;;Ford, K.G. et al. (Jan. 2001). “Protein Transduction: An Alternative to Genetic Intervention?” Gene Ther 8(1):1-4.;;Gao, Z.H. et al. (Jun. 1995). “Controlled release of a contraceptive steroid from biodegradable and injectable gel formulations: in vitro evaluation,” Pharm. Res 12(6):857-863.;;Henikoff, S. et al. (Nov. 15, 1989). “Amino acid substitution matrices from protein blocks,” Proc. Natl. Acad. Sci. USA 89(22):10915-10919.;;International Search Report dated Jan. 18, 2019, for PCT Application No. PCT/US2018/056943, filed Oct. 22, 2018, 5 pages.;;Jeeninga, R.E. et. al. (Apr. 2000). “Functional Differences Between the Long Terminal Repeat Transcriptional Promoters of Human Immunodeficiency Virus Type 1 Subtypes A Through G,” J Virol 74(8):3740-3751.;;Karlin, S. et al. (Jun. 15, 1993). “Applications and Statistics for Multiple High-Scoring Segments in Molecular Sequences,” PNAS USA 90(12):5873-5877.;;Klaver, B. et al. (Jun. 1994). “Comparison of 5′ and 3′ Long Terminal Repeat Promoter Function in Human Immunodeficiency Virus,” J Virol 68(6):3830-3840.;;Needleman, S.B. et al. (Mar. 1970). “A general method applicable to the search for similarities in the amino acid sequence of two proteins,” J Mol Biol 48(3):443-453.;;Nishitsuji, H. et al. (Jul. 8, 2015, e-published Jun. 19, 2015). “ZNF10 Inhibits HIV-1 LTR Activity Through Interaction With NF-κB and Sp1 Binding Motifs,” FEBS Lett 589(15):2019-2025.;;Ostro, M.J. et al. (Aug. 1989). “Use of liposomes as injectable-drug delivery systems,” Am J Hosp Pharm 46(8):1576-1587.;;Palva, I. et al. (May-Jun. 1983). “Secretion of Interferon by Bacillus Subtilis,” Gene 22(2-3):229-235.;;Pearson, W.R. et al. (Apr. 1988). “Improved tools for biological sequence comparison,” Proc. Nat'l. Acad. Sci. USA 85(8):2444-2448.;;Prochiantz, A. (Feb. 2007). “For Protein Transduction, Chemistry Can Win Over Biology,” Nat Methods 4(2):119-120.;;Rao. K.P. (1995). “Recent developments of collagen-based materials for medical applications and drug delivery systems,” J. Biomater Sci. Polym. Ed. 7(7):623-645.;;Saayman, S.M. et al. (Mar. 2016, e-published Nov. 19, 2015). “Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator Comple,” Mol Ther.24(3):488-498.;;Sakkhachornphop, S. et al. (Nov. 2009). “Designed Zinc Finger Protein Interacting With the HIV-1 Integrase Recognition Sequence at 2-LTR-circle Junctions,” Protein Sci 18(11):2219-2230.;;Smith, T.F. et al. (1981). “Comparison of Biosequences,” Adv. Appl. Math 2:482-489.;;Wang, P. et al. (May 2014, e-published Mar. 13, 2014). “Specific Reactivation of Latent HIV-1 With Designer Zinc-Finger Transcription Factors Targeting the HIV-1 5′-LTR Promoter,” Gen Ther 21(5):490-495.;;Written Opinion dated Jan. 18, 2019, for PCT Application No. PCT/US2018/056943, filed Oct. 22, 2018, 5 pages.",ACTIVE
45,US,A1,US 2023/0109505 A1,060-970-940-054-249,2023-04-06,2023,US 202117802628 A,2021-02-26,US 202117802628 A;;US 202062981907 P;;US 2021/0019942 W,2020-02-26,SMALL MOLECULE INHIBITORS OF SCL15A4 WITH ANTI-INFLAMMATORY ACTIVITY,"Disclosed are small molecule inhibitors of SLC15A4, and methods of using them to treat pDC-mediated diseases and conditions.",SCRIPPS RESEARCH INST,LAZAR DANIEL;;JADHAV APPASO;;PARKER CHRISTOPHER GEORGE;;TEIJARO JOHN ROSS,THE SCRIPPS RESEARCH INSTITUTE (2021-08-09),https://lens.org/060-970-940-054-249,Patent Application,yes,0,0,8,8,0,C07D471/04;;C07D235/30;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;A61P29/00;;C07D413/14;;C07D403/12;;A61K31/4184;;A61K31/428;;A61K31/4725;;A61K31/437;;A61P25/00;;A61P29/00;;C07D417/12;;C07D401/12;;C07D471/04;;C07D235/30;;C07D403/14;;C07D405/12;;C07D209/08;;C07D209/86;;C07D235/30;;C07D401/12;;C07D401/14;;C07D403/06;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D471/04,C07D403/12;;C07D209/08;;C07D209/86;;C07D235/30;;C07D401/12;;C07D401/14;;C07D403/06;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D471/04,,0,0,,,,DISCONTINUED
46,WO,A1,WO 2021/174023 A1,150-167-959-709-532,2021-09-02,2021,US 2021/0019942 W,2021-02-26,US 202062981907 P,2020-02-26,SMALL MOLECULE INHIBITORS OF SCL15A4 WITH ANTI-INFLAMMATORY ACTIVITY,"Disclosed are small molecule inhibitors of SLC15A4, and methods of using them to treat pDC-mediated diseases and conditions.",SCRIPPS RESEARCH INST;;LAZAR DANIEL;;JADHAV APPASO,LAZAR DANIEL;;JADHAV APPASO;;PARKER CHRISTOPHER GEORGE;;TEIJARO JOHN ROSS,,https://lens.org/150-167-959-709-532,Patent Application,yes,4,0,8,8,0,C07D471/04;;C07D235/30;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;A61P29/00;;C07D413/14;;C07D403/12;;A61K31/4184;;A61K31/428;;A61K31/4725;;A61K31/437;;A61P25/00;;A61P29/00;;C07D417/12;;C07D401/12;;C07D471/04;;C07D235/30;;C07D403/14;;C07D405/12;;C07D209/08;;C07D209/86;;C07D235/30;;C07D401/12;;C07D401/14;;C07D403/06;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D471/04,C07D235/30;;A61K31/4168;;A61P29/00;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D413/14;;C07D471/04,,84,81,016-714-310-009-074;;007-364-858-655-289;;119-018-196-745-072;;021-766-070-111-71X;;049-406-007-314-781;;065-363-884-599-988;;026-409-291-704-451;;030-490-954-563-49X;;134-095-706-125-299;;086-889-684-284-111;;028-413-908-255-903;;016-714-310-009-074;;099-866-070-019-188;;030-074-167-218-010;;008-149-759-837-073;;025-033-185-867-469;;110-150-812-105-978;;029-704-151-180-685;;033-496-200-492-097;;000-048-892-412-37X;;064-377-573-464-315;;131-995-043-336-013;;067-353-803-207-430;;087-544-903-537-055;;048-972-382-434-654;;027-039-384-646-730;;026-810-917-845-151;;093-829-990-201-555;;018-341-384-669-394;;027-616-260-208-509;;001-098-133-671-700;;003-857-642-732-652;;010-397-745-070-742;;084-074-183-861-419;;019-667-911-446-923;;080-433-690-791-116;;079-595-938-257-184;;061-103-974-339-868;;018-832-901-815-545;;125-502-328-933-449;;054-144-078-840-758;;074-236-724-113-496;;010-290-447-124-60X;;133-293-200-489-707;;001-008-405-620-295;;122-068-258-304-605;;024-015-198-439-986;;075-967-220-855-790;;088-429-905-272-751;;056-803-891-794-52X;;010-249-999-253-528;;022-060-387-728-461;;141-085-732-062-951;;020-348-265-570-483;;100-344-496-013-029;;010-249-999-253-528;;043-345-220-600-002;;049-216-158-568-925;;040-073-533-611-807;;022-060-387-728-461;;021-911-133-012-347;;017-114-778-526-357;;060-188-806-868-743;;033-114-597-096-810;;121-687-013-322-078;;002-168-765-272-596;;030-318-790-367-577;;077-681-889-128-586;;017-570-533-443-616;;026-600-614-319-36X;;047-435-506-484-46X;;025-232-296-042-138;;081-973-207-383-416;;034-488-172-654-189;;067-189-223-404-997;;048-943-179-547-626;;020-030-854-341-267;;045-537-229-572-596;;031-230-056-812-955;;033-002-201-539-085;;152-394-681-088-155,10.1146/annurev-immunol-031210-101345;;21219184;;pmc4160806;;10.1002/jps.2600660104;;833720;;10.1146/annurev.bi.55.070186.003311;;2874766;;10.1146/annurev.biochem.55.1.663;;pmc4292165;;25301932;;10.1101/cshperspect.a016246;;20346772;;10.1016/j.immuni.2010.03.012;;pmc3835203;;24054327;;10.1016/j.immuni.2013.08.037;;10.1016/j.jbspin.2010.09.005;;20961794;;pmc4654312;;25418467;;10.1038/cmi.2014.112;;10.1038/ni1112;;15454922;;28632714;;10.1038/ni.3731;;pmc5791156;;10.1016/j.coi.2013.10.006;;pmc4309276;;24246388;;10.1146/annurev-immunol-031210-101345;;21219184;;pmc4160806;;10.1038/nri2358;;18641647;;12471096;;10.4049/jimmunol.169.12.6673;;16633346;;10.1038/ni1333;;10.1016/j.immuni.2008.09.002;;18799143;;10.4049/jimmunol.0901175;;19890051;;pmc3351849;;10.1016/s1074-7613(03)00208-5;;12932356;;10.1007/s00393-017-0274-8;;28204879;;11222448;;10.1093/brain/124.3.480;;10.1084/jem.20071030;;pmc2118531;;17984305;;28785220;;10.3389/fphar.2017.00460;;pmc5506195;;30546008;;pmc6292890;;10.1038/s12276-018-0191-1;;10.3389/fphys.2017.00508;;pmc5516312;;28769820;;10.1208/ps020216;;11741232;;pmc2751030;;10.1042/0264-6021:3560053;;pmc1221811;;10.1042/bj3560053;;11336635;;10.1074/jbc.m410041200;;15522866;;pmc4272446;;10.1016/j.immuni.2014.12.010;;25526305;;29784761;;pmc6039277;;10.4049/jimmunol.1800210;;24695226;;10.1038/nature13133;;10.1053/j.gastro.2011.01.041;;21277849;;21045126;;pmc2993408;;10.1073/pnas.1014051107;;23382217;;pmc3581947;;10.1073/pnas.1222798110;;10.1007/s00296-013-2864-3;;24091983;;18259684;;10.1007/s10038-008-0254-6;;26232220;;10.1016/j.cell.2015.07.022;;26111766;;pmc4698371;;10.1038/nrd4626;;25601541;;pmc4323623;;10.1016/j.it.2014.12.004;;29651895;;10.1080/09687688.2018.1448123;;25175311;;10.1016/j.coph.2014.07.007;;pmc5559281;;10.1016/j.ccell.2017.07.010;;28810148;;10.1038/nrd2220;;17290284;;19073276;;10.1016/j.drudis.2008.11.007;;15602551;;10.1038/nature03193;;10.1002/anie.200462457;;15674983;;28111073;;10.1016/j.cell.2016.12.029;;pmc5632530;;pmc6874898;;10.26434/chemrxiv.7764638;;10.1038/s41557-019-0351-5;;10.26434/chemrxiv.7764638.v1;;31659311;;10.1074/jbc.m109.033670;;19570976;;pmc2749154;;pmc5826766;;29224352;;10.1021/acs.molpharmaceut.7b00728;;pmc5845931;;10.1016/j.str.2018.01.005;;29429879;;15307186;;10.1002/eji.200425218;;10.1084/jem.20100682;;21402738;;pmc3135342;;pmc5446938;;10.1016/j.coi.2016.10.003;;27907816;;10.1038/ncomms2949;;23752491;;pmc4976034;;27421483;;10.4049/jimmunol.1502357;;15307186;;10.1002/eji.200425218;;9590221;;10.4049/jimmunol.160.10.4755;;11049981;;10.1182/blood.v96.9.3029;;10.1182/blood.v96.9.3029.h8003029_3029_3039;;26787880;;10.1073/pnas.1525356113;;pmc4747766;;10.1084/jem.20100682;;21402738;;pmc3135342;;10.1038/nbt.1611;;20208520;;pmc4659944;;26525107;;10.1038/ncomms9777;;29053970;;pmc5704964;;10.1016/j.cell.2017.09.046;;10.1038/nature14107;;pmc4376665;;25561175;;10.1074/jbc.m110.197178;;pmc3023499;;21097499;;19497727;;10.1016/j.ceb.2009.04.014;;10.15252/embr.201338403;;24916388;;pmc4149780;;21141861;;pmc3016050;;10.1021/ja1083909;;10.1073/pnas.1813715116;;30602453;;pmc6338836;;25238095;;10.1016/j.immuni.2014.08.011;;10.1038/s41589-018-0155-8;;pmc6263940;;30420694;;10.4049/jimmunol.1801627;;pmc6478521;;30885957;;10.1007/978-1-61779-527-5_12;;22262442;;10.1021/acscentsci.7b00420;;pmc5746860;;29296668;;10.1126/scitranslmed.aam7621;;28904227;;pmc5628019;;31748741;;pmc6895438;;10.1038/s41586-019-1774-2;;10.1532/ijh97.04116;;15765784;;pmc2185049;;10.1084/jem.148.5.1198;;309911;;26447229;;10.4049/jimmunol.1501157;;pmc7569487;;pmc3956176;;24572573;;10.1073/pnas.1400593111;;pmc3176439;;21925319;;10.1016/j.cell.2011.08.015,"BORIS REIZIS ET AL: ""Plasmacytoid Dendritic Cells: Recent Progress and Open Questions"", ANNUAL REVIEW OF IMMUNOLOGY, vol. 29, no. 1, 23 April 2011 (2011-04-23), pages 163 - 183, XP055082976, ISSN: 0732-0582, DOI: 10.1146/annurev-immunol-031210-101345;;UNITED STATES PATENT OFFICE MANUAL OF PATENT EXAMINING PROCEDURES;;BERGE ET AL.: ""Pharmaceutical Salts"", J. PHARM. SCI., vol. 66, 1977, pages 1 - 19, XP002675560, DOI: 10.1002/jps.2600660104;;MELLMAN IFUCHS RHELENIUS A: ""Acidification of the endocytic and exocytic pathways"", ANNU REV BIOCHEM., vol. 55, 1986, pages 663 - 700;;PANDEY SKAWAI TAKIRA S: ""Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors"", COLD SPRING BARB PERSPECT BIOL., vol. 7, no. 1, 2014, pages a016246;;BLASIUS ALBEUTLER B: ""Intracellular toll-like receptors"", IMMUNITY, vol. 32, no. 3, 2010, pages 305 - 15;;WEN HMIAO EATING JP: ""Mechanisms of NOD-like receptor-associated inflammasome activation"", IMMUNITY, vol. 39, no. 3, 2013, pages 432 - 41;;RICHEZ C.BLANCO P.RIFKIN I.MOREAU JFSCHAEVERBEKE T: ""Role for toll-like receptors in autoimmune disease: The example of systemic lupus erythematosus"", JOINT BONE SPINE., vol. 78, no. 2, 2011, pages 124 - 30, XP028172165, DOI: 10.1016/j.jbspin.2010.09.005;;MA ZYZHANG EJYANG DLLU MJ: ""Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses"", CELLULAR & MOLECULAR IMMUNOLOGY, vol. 12, no. 3, 2015, pages 273 - 82;;IWASAKI AMEDZHITOV R: ""Toll-like receptor control of the adaptive immune responses"", NATURE IMMUNOLOGY, vol. 5, no. 10, 2004, pages 987 - 95, XP002535910, DOI: 10.1038/ni1112;;THEOFILOPOULOS ANKONO DHBACCALA R: ""The multiple pathways to autoimmunity"", NAT IMMUNOL, vol. 18, no. 7, 2017, pages 716 - 24;;KONO DH.BACCALA R.THEOFILOPOULOS AN.: ""TLRs and interferons: a central paradigm in autoimmunity"", CURR OPIN IMMUNOL, vol. 25, no. 6, 2013, pages 720 - 7;;REIZIS BBUNIN AGHOSH HSLEWIS KLSISIRAK V: ""Plasmacytoid dendritic cells: recent progress and open questions"", ANNU REV IMMUNOL, vol. 29, 2011, pages 163 - 83, XP055082976, DOI: 10.1146/annurev-immunol-031210-101345;;GILLIET MCAO WLIU YJ: ""Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases"", NAT REV IMMUNOL, vol. 8, no. 8, 2008, pages 594 - 606, XP055548464, DOI: 10.1038/nri2358;;PENNA GVULCANO MRONCARI AFACCHETTI F.SOZZANI SADORINI L.: ""Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells."", J IMMUNOL., vol. 169, no. 12, 2002, pages 6673 - 6;;OCHANDO JCHOMMA CYANG YHIDALGO AGARIN ATACKE F.ANGELI VLI YBOROS PDING Y: ""Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts"", NAT IMMUNOL, vol. 7, no. 6, 2006, pages 652 - 62;;VILLADANGOS JAYOUNG L: ""Antigen-presentation properties of plasmacyoid dendritic cells"", IMMUNITY, vol. 29, no. 3, 2008, pages 352 - 61;;DING CCAI YMARROQUIN JILDSTAD STYAN J.: ""Plasmacytoid dendritic cells regulate autoreactive B cell activation via soluble factors and in a cell-to-cell contact manner"", J IMMUNOL., vol. 183, no. 11, 2009, pages 7140 - 9;;JEGO GPALUCKA AKBLANCK JPCHALOUNI C.PASCUAL VBANCHEREAU J: ""Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6"", IMMUNITY, vol. 19, 2003, pages 225 - 34;;YUAN YMA HYE ZJING WJIANG Z: ""Interferon-stimulated gene 15 expression in systemic lupus erythematosus : Diagnostic value and association with lymphocytopenia"", Z RHEUMATOL, vol. 77, no. 3, 2018, pages 256 - 62;;PASHENKOV MHUANG YMKOSTULAS VHAGLUND MSODERSTROM MLINK H: ""Two subsets of dendritic cells are present in human cerebrospinal fluid"", BRAIN, vol. 124, no. 3, 2001, pages 480 - 92;;SERAFINI BROSICARELLI BFRANCIOTTA DMAGLIOZZI RREYNOLDS RCINQUE PANDREONI LTRIVEDI PSALVETTI MFAGGIONI A: ""Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain"", J EXP MED., vol. 204, no. 12, 2007, pages 2899 - 912;;LI PZHENG YCHEN X: ""Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics"", FRONT PHARMACOL, vol. 8, 2017, pages 460;;DARVIN PTOOR SMSASIDHARAN NAIR VELKORD E: ""Immune checkpoint inhibitors: recent progress and potential biomarkers"", EXP MOL MED, vol. 50, no. 12, 2018, pages 165, XP055615613, DOI: 10.1038/s12276-018-0191-1;;GAO WXIONG YLI QYANG H: ""Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics"", FRONTIERS IN PHYSIOLOGY, vol. 8, 2017;;BOTKA CWWITTIG TWGRAUL RCNIELSEN CU.HIGAKA K: ""Amidon GL, Sadee W. Human proton/oligopeptide transporter (POT) genes: identification of putative human genes using bioinformatics"", AAPS PHARMSCI, vol. 2, no. 2, 2000, pages E16;;SAKATA KYAMASHITA TMAEDA MMORIYAMA YSHIMADA STOHYAMA M: ""Cloning of a lymphatic peptide/histidinc transporter"", BIOCHEM J, vol. 356, no. 1, 2001, pages 53 - 60, XP008120905, DOI: 10.1042/0264-6021:3560053;;YAMASHITA TSHIMADA SGUO WSATO KKOHMURA EHAYAKAWA TTAKAGI TTOHYAMA M: ""Cloning and functional expression of a brain peptide/histidine transporter"", J BIOL CHEM., vol. 272, no. 15, 1997, XP001055034, DOI: 10.1074/jbc.272.17.11408;;NAKAMURA N.TANAKA STEKO YMITSUI KKANAZAWA H: ""Four Na+/H+ exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation"", J BIOL CHEM, vol. 280, no. 2, 2005, pages 1561 - 72;;CARUSO RWARNER NINOHARA NNUNEZ G: ""NOD1 and NOD2: signaling, host defense, and inflammatory disease"", IMMUNITY, vol. 41, no. 6, 2014, pages 898 - 908;;HU YSONG FJIANG HNUNEZ GSMITH DE.: ""SLC15A2 and SLC15A4 Mediate the Transport of Bacterially Derived Di/Tripeptides To Enhance the Nucleotide-Binding Oligomerization Domain-Dependent Immune Response in Mouse Bone Marrow-Derived Macrophages"", J IMMUNOL., vol. 201, no. 2, 2018, pages 652 - 62;;NAKAMURA NLILL JRPHUNG QJIANG ZSBAKALARSKI CDE MAZIERE AKLUMPERMAN JSCHLATTER MDELAMARRE LMELLMAN I: ""Endosomes are specialized platforms for bacterial sensing and NOD2 signalling"", NATURE, vol. 509, no. 7499, 2014, pages 240 - 4;;SASAWATARI SOKAMURA T.KASUMI ETANAKA-FURUYAMA KYANOBU-TAKANASHI RSHIRASAWA SKATO NTOYAMA-SORIMACHI N: ""The solute carrier family 15A4 regulates TLR9 and NODI functions in the innate immune system and promotes colitis in mice"", GASTROENTEROLOGY, vol. 140, no. 5, 2011, pages 1513 - 25, XP028196826, DOI: 10.1053/j.gastro.2011.01.041;;BLASIUS ALARNOLD CNGEORGEL PRUTSCHMANN SXIA YLIN PROSS CLI XSMART NGBEUTLER B: ""Slcl5a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells"", PROC NATL ACAD SCI USA., vol. 107, no. 46, 2010, pages 19973 - 8;;BACCALA RGONZALEZ-QUINTIAL RBLASIUS ALRIMANN IOZ.ATO KKONO DHBEUTLER BTHEOFILOPOULOS AN: ""Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus"", PROC NATL ACAD SCI U S A., vol. 110, no. 8, 2013, pages 2940 - 5;;ZUO XBSHENG YJHU SJGAO JPLI YTANG HYTANG XFCHENG HYIN XYWEN LL: ""Variants in TNFSF4, TNFAIP3. INIPI, BLK, SLC15A4 and UBE2L3 interact to confer risk of systemic lupus erythematosus in Chinese population"", RHEUMATOLOGY INTERNATIONAL, vol. 34, no. 4, 2014, pages 459 - 64;;TAKEUCHI FOCHIAI YSERIZAWA MYANAI KKUZUYA NKAJIO HHONJO STAKEDA NKABURAGI YYASUDA K: ""Search for type 2 diabetes susceptibility genes on chromosomes lq, 3q and 12q"", JOURNAL OF HUMAN GENETICS, vol. 53, no. 4, 2008, pages 314 - 24, XP037012915, DOI: 10.1007/s10038-008-0254-6;;CESAR-RAZQUIN ASNIJDER BFRAPPIER-BRINTON TISSERLIN RGYIMESI GBAI XREITHMEIER RAHEPWORTH DHEDIGER MAEDWARDS AM: ""A Call for Systematic Research on Solute Carriers"", CELL, vol. 162, no. 3, 2015, pages 478 - 87, XP029248055, DOI: 10.1016/j.cell.2015.07.022;;LIN LYEE SWKIM RBGIACOMINI KM: ""SLC transporters as therapeutic targets: emerging opportunities"", NAT REV DRUG DISCOV, vol. 14, no. 8, 2015, pages 543 - 60;;O'SULLIVAN DPEARCE EL: ""Targeting T cell metabolism for therapy"", TRENDS IN IMMUNOLOGY, vol. 36, no. 2, 2015, pages 71 - 80, XP055322656, DOI: 10.1016/j.it.2014.12.004;;WANG WWGALLO LJADHAV AHAWKINS RPARKER CG: ""The Druggability of Solute Carriers"", J MED CHEM., 2019;;BAI XMORAES TFREITHMEIER RAF: ""Structural biology of solute carrier (SLC) membrane transport proteins"", MOL MEMBR BIOL, vol. 34, no. 1-2, 2017, pages 1 - 32;;BLAGG JWORKMAN P: ""Chemical biology approaches to target validation in cancer"", CURR OPIN PHARMACOL, vol. 17, 2014, pages 87 - 100;;BLAGG JWORKMAN P: ""Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology"", CANCER CELL, vol. 32, no. 2, 2017, pages 268 - 70;;HAJDUK PJGREER J: ""A decade of fragment-based drug design: strategic advances and lessons learned"", NATURE REVIEWS DRUG DISCOVERY, vol. 6, no. 3, 2007, pages 211 - 9, XP002599578, DOI: 10.1038/NRD2220;;BEMBENEK SDTOUNGE BAREYNOLDS CH: ""Ligand efficiency and fragment-based drug discovery"", DRUG DISCOVERY TODAY, vol. 14, no. 5-6, 2009, pages 278 - 83, XP025971987, DOI: 10.1016/j.drudis.2008.11.007;;LIPINSKI CHOPKINS A: ""Navigating chemical space for biology and medicine"", NATURE, vol. 432, no. 7019, 2004, pages 855 - 61;;FINK TBRUGGESSER HREYMOND JL: ""Virtual exploration of the small-molecule chemical universe below 160 Daltons"", ANGEW CHEM LNT ED ENGL., vol. 44, no. 10, 2005, pages 1504 - 8;;PARKER CGGALMOZZI AWANG YCORREIA BESASAKI KJOSLVN CMKIM ASCAVALLARO CLLAWRENCE RMJOHNSON SR: ""Saez E, Cravatt BF. Ligand and Target Discovery by Fragment-Based Screening in Human Cells"", CELL, vol. 168, no. 3, 2017, pages 52741;;WANG YDIX MMBIANCO GREMSBERG JRLEE HYKALOCSAY MGYGI SPFORLI SVITE GLAWRENCE RM: ""Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs"", NAT CHEM, vol. 11, no. 1 2, 2019, pages 1113 - 23, XP037114906, DOI: 10.1038/s41557-019-0351-5;;LEE JTATTOLI IWOJTAL KAVAVRICKA SRPHILPOTT DJGIRARDIN SE: ""pH-dependent internalization of muramvl peptides from early endosomes enables Nod I and Nod2 signaling"", J BIOL CHEM., vol. 284, no. 35, 2009, pages 23818 - 29;;SONG FFHU YJWANG YQSMITH DEJIANG HD: ""Functional Characterization of Human Peptide/Histidine Transporter 1 in Stably Transfected MDCK Cells"", MOLECULAR PHARMACEUTICS, vol. 15, no. 2, 2018, pages 385 - 93;;MARTINEZ MOLLEDO MQUISTGAARD EMFLAYHAN APIEPRZYK JLOW C: ""Multispecific Substrate Recognition in a Proton-Dependent Oligopeptide Transporter"", STRUCTURE, vol. 26, no. 3, 2018, pages 467 - 76, XP085357826, DOI: 10.1016/j.str.2018.01.005;;RUTZ MMETZGER JGELLERT TLUPPA PLIPFORD GBWAGNER HBAUER S: ""Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner"", EUROPEAN JOURNAL OF IMMUNOLOGY, vol. 34, no. 9, 2004, pages 2541 - 50;;EWALD SEENGEL ALEE JWANG MBOGYO MBARTON GM: ""Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase"", J EXP MED., vol. 208, no. 4, 2011, pages 643 - 51;;MAJER OLIU BBARTON GM: ""Nucleic acid-sensing TLRs: trafficking and regulation"", CURRENT OPINION IN IMMUNOLOGY, vol. 44, 2017, pages 26 - 33, XP085043316, DOI: 10.1016/j.coi.2016.10.003;;ONJI MKANNO ASAITOH SIFUKUI RMOTOI YSHIBATA TMATSUMOTO FLAMICHHANE ASATO SKIYONO H: ""An essential role for the N-terminal fragment of Toll-like receptor 9 in DNA sensing"", NATURE COMMUNICATIONS, vol. 4, 2013;;SINHA SSCAMERON JBROOKS JCLEIFER CA: ""Complex Negative Regulation of TLR9 by Multiple Proteolytic Cleavage Event"", JOURNAL OF IMMUNOLOGY, vol. 197, no. 4, 2016, pages 1343 - 52;;RUTZ MMETZGER JGELLERT TLUPPA PLIPFORD GBWAGNER HBAUER S: ""Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner"", EUR J IMMUNOL., vol. 34, no. 9, 2004, pages 2541 - 50;;YI AKTUETKEN RREDFORD TWALDSCHMIDT MKIRSCH JKRIEG AM: ""CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species"", J IMMUNOL., vol. 160, no. 10, 1998, pages 4755 - 61, XP002979516;;BRASEL KDE SMEDT TSMITH JLMALISZEWSKI CR: ""Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures"", BLOOD, vol. 96, no. 9, 2000, pages 3029 - 39, XP086508054, DOI: 10.1182/blood.V96.9.3029;;TEIJARO JRSTUDER SLEAF NKIOSSES WBNGUYEN NMATSUKI KNEGISHI HTANIGUCHI TOLDSTONE MBROSEN H: ""S1PR1-mediated IFNAR1 degradation modulates plasmacytoid dendritic cell interferon-alpha autoamplification"", PROC NATL ACAD SCI U S A., vol. 113, no. 5, 2016, pages 1351 - 6;;EWALD SEENGEL ALEE JWANG MQBOGYO MBARTON GM: ""Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase"", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 208, no. 4, 2011, pages 643 - 51;;KLEIFELD ODOUCET AAUF DEM KELLER UPRUDOVA ASCHILLING OKAINTHAN RKSTARR AEFOSTER LJKIZHAKKEDATHU JNOVERALL CM: ""Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products"", NAT BIOTECHNOL., vol. 28, no. 3, 2010, pages 281 - 8, XP002753523, DOI: 10.1038/nbt.1611;;KLEIN TFUNG SYRENNER FBLANK MADUFOUR AKANG SBOLGER-MUNRO MSCURLL JMPRIATEL JJSCHWEIGLER P: ""Overall CM. The paracaspase MALT1 cleaves HOIL1 reducing linear ubiquitination by LUBAC to dampen lymphocyte NF-kappaB signalling"", NAT COMMUN, vol. 6, 2015, pages 8777;;WYANT GAABU-REMAILEH MWOLFSON RLCHEN WWFREINKMAN EDANAI LVHEIDEN MGVSABATINI DM: ""mTORCI Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient"", CELL, vol. 171, no. 3, 2017, pages 642, XP085233905, DOI: 10.1016/j.cell.2017.09.046;;REBSAMEN MPOCHINI LSTASYK TDE ARAUJO MEGGALLUCCIO MKANDASAMY RKSNIJDER BFAUSTER ARUDASHEVSKAYA ELBRUCKNER M: ""SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORCl"", NATURE, vol. 519, no. 7544, 2015, pages 477, XP055209684, DOI: 10.1038/nature14107;;MATTERA RBOEHM MCHAUDHURI RPRABHU YBONIFACINO JS: ""Conservation and diversification of dileucine signal recognition by adaptor protein (AP) complex variants"", J BIOL CHEM., vol. 286, no. 3, 2011, pages 2022 - 30;;DELL'ANGELICA EC: ""AP-3-dependent trafficking and disease: the first decade"", CURR OPIN CELL BIOL, vol. 21, no. 4, 2009, pages 552 - 9, XP026434722;;LYONS JAPARKER JLSOICAN NBRINTH ALI DSHAH STCAFFREY MNEWSTEAD S: ""Structural basis for polyspecificitv in the POT family of proton-coupled oligopeptide transporters"", EMBO REP, vol. 15, no. 8, 2014, pages 886 - 93;;SZYCHOWSKI JMAHDAVI AHODAS JJBAGERT JDNGO JTLANDGRAF PDIETERICH DCSCHUMAN EMTIRRELL DA: ""Cleavable biotin probes for labeling of biomolecules via azide-alkyne cycloaddition"", J AM CHEM SOC., vol. 132, no. 51, 2010, pages 18351 - 60, XP055029467, DOI: 10.1021/ja1083909;;MINHAS GSNEWSTEAD S: ""Structural basis for prodrug recognition by the SLC 15 family of proton-coupled peptide transporters"", PROC NATL ACAD SCI USA., vol. 116, no. 3, 2019, pages 804 - 9;;KOBAYASHI TSHIMABUKURO-DEMOTO SYOSHIDA-SUGITANI RFURUYAMA-TANAKA KKARYU HSUGIURA YSHIMIZU YHOSAKA TGOTO MKATO N: ""The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatorv responses and pathogenic antibody production"", IMMUNITY, vol. 41, no. 3, 2014, pages 375 - 88;;OGASAWARA DICHU TAVARTABEDIAN VFBENTHUYSEN JJING HREED AULANOVSKAYA OAHULCE JJROBERTS ABROWN S: ""Selective blockade of the lvso-PS lipase ABHD12 stimulates immune responses in vivo"", NAT CHEM BIOL., vol. 14, no. 12, 2018, pages 1099 - 108, XP036637462, DOI: 10.1038/s41589-018-0155-8;;ZARO BWVINOGRADOVA EVLAZAR DCBLEWETT MMSUCIU RMTAKAYA JSTUDER SDE LA TORRE JCCASANOVA JLCRAVATT BF: ""Dimethyl Fumarate Disrupts Human Innate Immune Signaling by Targeting the IRAK4-MyD88 Complex"", J IMMUNOL., vol. 202, no. 9, 2019, pages 2737 - 46;;MANZANERO S: ""Generation of mouse bone marrow-derived macrophages"", METHODS MOL BIOL, vol. 844, 2012, pages 177 - 81;;PARKER CGKUTTRUFF CAGALMOZZI AJORGENSCN LYEH CHHERMANSON DJWANG YJARTOLA MMCKERRALL SJJOSYLN CM: ""Chemical Proteomics Identifies SLC25A20 as a Functional Target of the Ingenol Class of Actinic Keratosis Drugs"", ACS CENTRAL SCIENCE, vol. 3, no. 12, 2017, pages 1276 - 85;;SCHONHOFT JDMONTEIRO CPLATE LEISELE YSKELLY JMBOLAND DPARKER CGCRAVATT BFTERUYA SHELMKE S: ""Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients"", SCIENCE TRANSLATIONAL MEDICINE, vol. 9, no. 407, 2017, XP055589739, DOI: 10.1126/scitranslmed.aam7621;;GALMOZZI AKOK BPKIM ASMONTENEGRO-BURKE JRLEE JYSPREAFICO RMOSURE SALBERT VCINTRON-COLON RGODIO C: ""PGRMC2 is an intracellular haem chaperone critical for adipocyte, function"", NATURE, vol. 576, no. 7785, 2019, pages 138, XP036953143, DOI: 10.1038/s41586-019-1774-2;;MAEDA TMURATA KFUKUSHIMA TSUGAHARA KTSURUDA KANAMI MONIMARU YTSUKASAKI KTOMONAGA MMORIUCHI R: ""A novel plasmacytoid dendritic cell line, CAL-I. established from a patient with blastic natural killer cell lymphoma"", LNT J HEMATOL, vol. 81, no. 2, 2005, pages 148 - 54, XP036522530, DOI: 10.1532/IJH97.04116;;ANDREWS BSEISENBERG RATHEOFILOPOULOS ANLZUI SWILSON CBMCCONAHEY PJMURPHY EDROTHS JBDIXON FJ: ""Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains"", J EXP MED., vol. 148, no. 5, 1978, pages 1198 - 215;;LIAO XLI SSETTLAGE RESUN SREN JREIHL AMZHANG HKARYALA SVREILLY CMAHMED SA: ""Cutting Edge: Plasmacytoid Dendritic Cells in Late-Stage Lupus Mice Defective in Producing IFN-alpha"", J IMMUNOL., vol. 195, no. 10, 2015, pages 4578 - 82;;TEIJARO JRWALSH KBRICE SROSEN HOLDSTONE MB: ""Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection"", PROC NATL ACAD SCI U S A., vol. 111, no. 10, 2014, pages 3799 - 804;;TEIJARO JRWALSH KBCAHALAN SFREMGEN DMROBERTS ESCOTT FMARTINBOROUGH EPEACH ROLDSTONE MBROSEN H: ""Endothelial cells arc central orchestrators of cytokine amplification during influenza virus infection"", CELL, vol. 146, no. 6, 2011, pages 980 - 91, XP028295711, DOI: 10.1016/j.cell.2011.08.015",PENDING
47,EP,A4,EP 2668505 A4,167-157-455-619-523,2014-05-21,2014,EP 12739581 A,2012-01-23,US 201161435704 P;;US 201161435724 P;;US 201161435721 P;;US 2012/0022248 W,2011-01-24,METHODS FOR OBTAINING SINGLE CELLS AND APPLICATIONS OF SINGLE CELL OMICS,,EPIC SCIENCES INC,YANG XING;;NELSON DAVID M;;KUHN PETER;;LAZAR DANIEL CHESNAYE,"EPIC SCIENCES, INC. (2016-11-16)",https://lens.org/167-157-455-619-523,Search Report,no,1,0,7,7,0,G01N33/56966;;G01N33/574;;G01N33/574;;G01N33/56966;;C12Q1/6886;;G01N33/57426,G01N33/574,,11,11,013-681-536-356-08X;;112-715-894-068-370;;030-555-608-327-181;;023-470-740-030-442;;058-863-498-751-897;;034-019-687-840-026;;037-683-830-699-745;;020-031-842-104-314;;058-215-345-503-707;;021-594-398-743-157;;004-011-084-978-734,10.1200/jco.2008.26.15_suppl.19118;;20111743;;pmc2810476;;10.1155/2010/861341;;20535130;;10.1038/jid.2010.141;;11786398;;10.1016/s0002-9440(10)64348-9;;pmc1867119;;10.1109/memsys.2010.5442361;;10.1016/j.critrevonc.2010.04.008;;20570170;;10.1158/1078-0432.ccr-04-0378;;15501967;;10623654;;pmc1868645;;10.1016/s0002-9440(10)64706-2;;10.1016/j.chroma.2007.05.064;;17561026;;pmc3101098;;21300848;;10.1083/jcb.201010021;;10.1073/pnas.1012539107;;20930119;;pmc2972993,"D MARRINUCCI ET AL: ""Bronchioloalveolar lung CTCs retain cytomorphologic features of primary tumor type"", JOURNAL OF CLINICAL ONCOLOGY, 20 March 2008 (2008-03-20), pages 19118, XP055112099, Retrieved from the Internet <URL:http://meeting.ascopubs.org/cgi/content/abstract/26/15_suppl/19118> [retrieved on 20140404];;DENA MARRINUCCI ET AL: ""Cytomorphology of Circulating Colorectal Tumor Cells: A Small Case Series"", JOURNAL OF ONCOLOGY, vol. 7, no. 12, 1 January 2010 (2010-01-01), pages 4080 - 7, XP055112146, ISSN: 1687-8450, DOI: 10.1016/S1470-2045(07)70140-7;;VINCENZO DE GIORGI ET AL: ""Application of a Filtration- and Isolation-by-Size Technique for the Detection of Circulating Tumor Cells in Cutaneous Melanoma"", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 130, no. 10, 10 June 2010 (2010-06-10), pages 2440 - 2447, XP055113195, ISSN: 0022-202X, DOI: 10.1038/jid.2010.141;;VONA G ET AL: ""Enrichment, immunomorphological, and genetic characterization of fetal cells circulating in maternal blood"", AMERICAN JOURNAL OF PATHOLOGY; [10640], ELSEVIER INC, US, vol. 160, no. 1, 1 January 2002 (2002-01-01), pages 51 - 58, XP002236986, ISSN: 0002-9440;;BO LU ET AL: ""Parylene membrane slot filter for the capture, analysis and culture of viable circulating tumor cells"", MICRO ELECTRO MECHANICAL SYSTEMS (MEMS), 2010 IEEE 23RD INTERNATIONAL CONFERENCE ON, IEEE, PISCATAWAY, NJ, USA, 24 January 2010 (2010-01-24), pages 935 - 938, XP031655081, ISBN: 978-1-4244-5761-8;;LIN H ET AL: ""Disseminated and circulating tumor cells: Role in effective cancer management"", CRITICAL REVIEWS IN ONCOLOGY / HEMATOLOGY, ELSEVIER SCIENCE IRELAND LTD., LIMERICK, IE, vol. 77, no. 1, 1 January 2011 (2011-01-01), pages 1 - 11, XP027597723, ISSN: 1040-8428, [retrieved on 20110101], DOI: 10.1016/J.CRITREVONC.2010.04.008;;ALLARD W J ET AL: ""Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases"", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 10, no. 20, 15 October 2004 (2004-10-15), pages 6897 - 6904, XP002489234, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-04-0378;;VONA GIOVANNA ET AL: ""Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulating tumor cells"", AMERICAN JOURNAL OF PATHOLOGY; [10640], ELSEVIER INC, US, vol. 156, no. 1, 1 January 2000 (2000-01-01), pages 57 - 63, XP002186868, ISSN: 0002-9440;;ZHENG ET AL: ""Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells"", JOURNAL OF CHROMATOGRAPHY, ELSEVIER SCIENCE PUBLISHERS B.V, NL, vol. 1162, no. 2, 4 August 2007 (2007-08-04), pages 154 - 161, XP022185542, ISSN: 0021-9673, DOI: 10.1016/J.CHROMA.2007.05.064;;M. YU ET AL: ""Circulating tumor cells: approaches to isolation and characterization"", THE JOURNAL OF CELL BIOLOGY, vol. 192, no. 3, 7 February 2011 (2011-02-07), pages 373 - 382, XP055020222, ISSN: 0021-9525, DOI: 10.1083/jcb.201010021;;S. L. STOTT ET AL: ""Isolation of circulating tumor cells using a microvortex-generating herringbone-chip"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 107, no. 43, 26 October 2010 (2010-10-26), pages 18392 - 18397, XP055113098, ISSN: 0027-8424, DOI: 10.1073/pnas.1012539107",DISCONTINUED
48,EP,A1,EP 4110764 A1,106-015-033-125-703,2023-01-04,2023,EP 21713803 A,2021-02-26,US 202062981907 P;;US 2021/0019942 W,2020-02-26,SMALL MOLECULE INHIBITORS OF SCL15A4 WITH ANTI-INFLAMMATORY ACTIVITY,,SCRIPPS RESEARCH INST,LAZAR DANIEL;;JADHAV APPASO;;PARKER CHRISTOPHER GEORGE;;TEIJARO JOHN ROSS,,https://lens.org/106-015-033-125-703,Patent Application,yes,0,0,8,8,0,C07D471/04;;C07D235/30;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;A61P29/00;;C07D413/14;;C07D403/12;;A61K31/4184;;A61K31/428;;A61K31/4725;;A61K31/437;;A61P25/00;;A61P29/00;;C07D417/12;;C07D401/12;;C07D471/04;;C07D235/30;;C07D403/14;;C07D405/12;;C07D209/08;;C07D209/86;;C07D235/30;;C07D401/12;;C07D401/14;;C07D403/06;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D471/04,C07D235/30;;A61K31/4168;;A61P29/00;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D413/14;;C07D471/04,,0,0,,,,PENDING
49,US,A1,US 2011/0167531 A1,136-761-159-928-264,2011-07-14,2011,US 21099608 A,2008-09-15,US 21099608 A;;US 97330807 A;;US 85002606 P,2006-10-06,Goggle Attachment System With a Tail for a Helmet,"A protective goggle assembly includes a protective goggle having two side straps, each side strap comprises a free end and a first surface attachment region adjacent to the free end on at least one surface of each side strap; and a strap assembly that encircles the user's head, on each side of the strap assembly a second surface attachment region is provided that is configured to engage the first surface attachment region of the side straps. Free ends of the base band of the strap assembly are connected to an elastic ring to form a complete encircling band. The base band has a tail for securing the base band in position on a helmet. The complete encircling band is configured to fit around a soldier's helmet and the elastic ring being configured to fit over and around a night vision goggle mount at a front of the helmet.",PACKARD DANIEL;;BORSA KIMBERLY;;LAZAR ADAM NORTH;;RADIGAN JAMES PATRICK,PACKARD DANIEL;;BORSA KIMBERLY;;LAZAR ADAM NORTH;;RADIGAN JAMES PATRICK,REYEWEAR ACQUISITION INC (2019-09-27);;REVISION MILITARY INC (2010-11-01);;REVISION MILITARY EYEWEAR (CANADA) INC (2019-09-26),https://lens.org/136-761-159-928-264,Patent Application,yes,12,1,2,6,0,A42B3/185;;A42B3/185,F41H1/04;;A61F9/02,2/6.7;;2/10,0,0,,,,INACTIVE
50,US,A1,US 2020/0255500 A1,000-835-304-398-261,2020-08-13,2020,US 201816756632 A,2018-10-22,US 201816756632 A;;US 201762575307 P;;US 2018/0056943 W,2017-10-20,COMPOSITION AND METHOD FOR ACTIVATING LATENT HUMAN IMMUNODEFICIENCY VIRUS (HIV),"Provided are compositions and methods for activating latent Human Immunodeficiency Virus (HIV). The compositions and methods may utilize a recombinant peptide that has a DNA binding zinc finger domain specific to the HIV long terminal repeat (LTR) sequence. The recombinant peptide may also have a transcription factor (e.g. a transcription activator) that is conjugated to the zinc finger domain. Also provided are methods of treating HIV in a subject in need of the treatment. The method may involve activation of latent HIV in cells of the subject and selectively removing such cells from the subject, providing complete and effective treatment of HIV.",HOPE CITY,MORRIS KEVIN V;;WEINBERG MARC S;;SCOTT TRISTAN;;LAZAR DANIEL,CITY OF HOPE (2017-11-08),https://lens.org/000-835-304-398-261,Patent Application,yes,0,1,4,4,18,A61K38/00;;C07K14/4705;;C07K2319/09;;C07K2319/10;;C07K2319/24;;A61P31/18;;C07K16/10;;C07K14/00,C07K16/10,,0,0,,,,ACTIVE
51,US,A1,US 2014/0308669 A1,104-799-694-045-634,2014-10-16,2014,US 201214001154 A,2012-01-23,US 201214001154 A;;US 201161435704 P;;US 201161435724 P;;US 201161435721 P;;US 2012/0022248 W,2011-01-24,METHODS FOR OBTAINING SINGLE CELLS AND APPLICATIONS OF SINGLE CELL OMICS,"The present application provides methods for obtaining single cells from a sample. Methods for isolating and analyzing molecular features obtained from a single cell are also disclosed herein. For example, individual circulating tumor cells (CTCs) from a sample such as a patient's blood sample can be identified and obtained using methods disclosed herein, and picked for further analysis.",YANG XING;;NELSON DAVID M;;KUHN PETER;;LAZAR DANIEL CHESNAYE;;EPIC SCIENCE INC,YANG XING;;NELSON DAVID M;;KUHN PETER;;LAZAR DANIEL CHESNAYE,THE SCRIPPS RESEARCH INSTITUTE (2013-11-19),https://lens.org/104-799-694-045-634,Patent Application,yes,2,20,7,7,0,G01N33/56966;;G01N33/574;;G01N33/574;;G01N33/56966;;C12Q1/6886;;G01N33/57426,G01N33/574;;C12Q1/68,435/6.12;;435/7.23,0,0,,,,DISCONTINUED
52,WO,A2,WO 2012/103025 A2,129-681-227-712-411,2012-08-02,2012,US 2012/0022248 W,2012-01-23,US 201161435704 P;;US 201161435724 P;;US 201161435721 P,2011-01-24,METHODS FOR OBTAINING SINGLE CELLS AND APPLICATIONS OF SINGLE CELL OMICS,"The present application provides methods for obtaining single cells from a sample. Methods for isolating and analyzing molecular features obtained from a single cell are also disclosed herein. For example, individual circulating tumor cells (CTCs) from a sample such as a patient's blood sample can be identified and obtained using methods disclosed herein, and picked for further analysis.",EPIC SCIENCES INC;;YANG XING;;NELSON DAVID M;;KUHN PETER;;LAZAR DANIEL CHESNAYE,YANG XING;;NELSON DAVID M;;KUHN PETER;;LAZAR DANIEL CHESNAYE,,https://lens.org/129-681-227-712-411,Patent Application,no,0,25,7,7,0,G01N33/56966;;G01N33/574;;G01N33/574;;G01N33/56966;;C12Q1/6886;;G01N33/57426,G01N33/574,,0,0,,,,PENDING
53,WO,A3,WO 2012/103025 A3,029-094-887-908-477,2012-09-20,2012,US 2012/0022248 W,2012-01-23,US 201161435704 P;;US 201161435724 P;;US 201161435721 P,2011-01-24,METHODS FOR OBTAINING SINGLE CELLS AND APPLICATIONS OF SINGLE CELL OMICS,"The present application provides methods for obtaining single cells from a sample. Methods for isolating and analyzing molecular features obtained from a single cell are also disclosed herein. For example, individual circulating tumor cells (CTCs) from a sample such as a patient's blood sample can be identified and obtained using methods disclosed herein, and picked for further analysis.",EPIC SCIENCES INC;;YANG XING;;NELSON DAVID M;;KUHN PETER;;LAZAR DANIEL CHESNAYE,YANG XING;;NELSON DAVID M;;KUHN PETER;;LAZAR DANIEL CHESNAYE,,https://lens.org/029-094-887-908-477,Search Report,yes,2,0,7,7,0,G01N33/56966;;G01N33/574;;G01N33/574;;G01N33/56966;;C12Q1/6886;;G01N33/57426,G01N33/574,,0,0,,,,PENDING
54,US,B2,US 8201275 B2,008-706-072-495-520,2012-06-19,2012,US 21099608 A,2008-09-15,US 21099608 A;;US 97330807 A;;US 85002606 P,2006-10-06,Goggle attachment system with a tail for a helmet,"A protective goggle assembly includes a protective goggle having two side straps, each side strap comprises a free end and a first surface attachment region adjacent to the free end on at least one surface of each side strap; and a strap assembly that encircles the user's head, on each side of the strap assembly a second surface attachment region is provided that is configured to engage the first surface attachment region of the side straps. Free ends of the base band of the strap assembly are connected to an elastic ring to form a complete encircling band. The base band has a tail for securing the base band in position on a helmet. The complete encircling band is configured to fit around a soldier's helmet and the elastic ring being configured to fit over and around a night vision goggle mount at a front of the helmet.",PACKARD DANIEL;;BORSA KIMBERLY;;LAZAR ADAM NORTH;;RADIGAN JAMES PATRICK;;REVISION MILITARY INC,PACKARD DANIEL;;BORSA KIMBERLY;;LAZAR ADAM NORTH;;RADIGAN JAMES PATRICK,REYEWEAR ACQUISITION INC (2019-09-27);;REVISION MILITARY INC (2010-11-01);;REVISION MILITARY EYEWEAR (CANADA) INC (2019-09-26),https://lens.org/008-706-072-495-520,Granted Patent,yes,12,5,2,6,0,A42B3/185;;A42B3/185,A42B1/24,2/422;;2/6.6;;2/410;;2/6.2;;2/414;;2/426;;2/452,0,0,,,,INACTIVE
55,US,A1,US 2022/0385532 A1,064-475-301-371-288,2022-12-01,2022,US 202117331253 A,2021-05-26,US 202117331253 A,2021-05-26,ADDING HOST SYSTEMS TO EXISTING CONTAINERIZED CLUSTERS,"The technology disclosed herein enables adding new host systems to existing clusters. An example method comprises receiving, by a processor, identification data associated with an existing cluster; generating a cluster entity data structure of the existing cluster using the identification data; generating a discovery image using the cluster configuration data structure, wherein the discover image comprises an executable code structured according to a file system; and causing a new host system to boot using the discovery image.",RED HAT INC,EREZ DANIEL;;LAZAR RONNIE;;COHEN ERAN;;SHNAIDMAN YEVGENY;;TRAEGER AVISHAY,RED HAT INC (2021-05-25),https://lens.org/064-475-301-371-288,Patent Application,yes,26,2,1,1,0,H04L63/0823;;H04L41/0895;;H04L41/0893;;H04L41/0816;;H04L67/133;;H04L67/10;;H04L41/0816;;H04L41/0886;;H04L63/0823;;H04L67/1097;;H04L67/133,H04L12/24;;H04L29/08;;H04L29/06,,0,0,,,,PENDING
56,TW,A,TW 201238003 A,121-527-337-299-422,2012-09-16,2012,TW 100147453 A,2011-12-20,US 97791810 A,2010-12-23,Field extension to reduce non-yielding exposures of wafer,"Techniques are provided for efficient lithography processing and wafer layout. In particular, the techniques can be used to reduce the number of sacrificial exposures along the wafer perimeter region. In one example embodiment, an exposure system reticle is configured with both a normal area (die yielding area) and a dumification area (non-yielding area at wafer perimeter), thereby allowing for lithographic processing in the non-yielding areas sufficient to facilitate successful processing in the adjacent die yielding areas, but without requiring additional sacrificial exposures. This reduction in sacrificial exposures translates to a significant improvement in fab capacity. The techniques can be implemented, for example, on any number of lithography tools having an adjustable reticle or reticle blind capability and in the context of any technology nodes, such as 95 nm and smaller. The lithography tool may produce wafers at a faster rate.",INTEL CORP,VARELA ALEJANDRO;;MAXIM MICHAEL A;;VANLARE DANIEL E;;LAZAR ADI,,https://lens.org/121-527-337-299-422,Patent of Addition,no,0,0,2,2,0,G03B27/42;;G03F1/38;;G03F7/70433;;G03F1/38;;G03B27/42;;G03F7/70433,H01L21/78;;G03F7/20;;H01L23/544,,0,0,,,,PENDING
57,CA,A1,CA 3173733 A1,036-148-676-400-66X,2021-09-02,2021,CA 3173733 A,2021-02-26,US 202062981907 P;;US 2021/0019942 W,2020-02-26,SMALL MOLECULE INHIBITORS OF SCL15A4 WITH ANTI-INFLAMMATORY ACTIVITY,"Disclosed are small molecule inhibitors of SLC15A4, and methods of using them to treat pDC-mediated diseases and conditions.",SCRIPPS RESEARCH INST,LAZAR DANIEL;;JADHAV APPASO;;PARKER CHRISTOPHER GEORGE;;TEIJARO JOHN ROSS,,https://lens.org/036-148-676-400-66X,Patent Application,no,0,0,8,8,0,C07D471/04;;C07D235/30;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;A61P29/00;;C07D413/14;;C07D403/12;;A61K31/4184;;A61K31/428;;A61K31/4725;;A61K31/437;;A61P25/00;;A61P29/00;;C07D417/12;;C07D401/12;;C07D471/04;;C07D235/30;;C07D403/14;;C07D405/12;;C07D209/08;;C07D209/86;;C07D235/30;;C07D401/12;;C07D401/14;;C07D403/06;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D471/04,A61K31/4168;;A61P29/00;;C07D235/30;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D413/14;;C07D471/04,,0,0,,,,PENDING
58,EP,A2,EP 2668505 A2,026-655-824-856-049,2013-12-04,2013,EP 12739581 A,2012-01-23,US 201161435704 P;;US 201161435724 P;;US 201161435721 P;;US 2012/0022248 W,2011-01-24,METHODS FOR OBTAINING SINGLE CELLS AND APPLICATIONS OF SINGLE CELL OMICS,,EPIC SCIENCES INC,YANG XING;;NELSON DAVID M;;KUHN PETER;;LAZAR DANIEL CHESNAYE,"EPIC SCIENCES, INC. (2016-11-16)",https://lens.org/026-655-824-856-049,Patent Application,yes,0,0,7,7,0,G01N33/56966;;G01N33/574;;G01N33/574;;G01N33/56966;;C12Q1/6886;;G01N33/57426,G01N33/574,,0,0,,,,DISCONTINUED
59,US,A1,US 2012/0162622 A1,082-437-997-208-58X,2012-06-28,2012,US 97791810 A,2010-12-23,US 97791810 A,2010-12-23,FIELD EXTENSION TO REDUCE NON-YIELDING EXPOSURES OF WAFER,"Techniques are provided for efficient lithography processing and wafer layout. In particular, the techniques can be used to reduce the number of sacrificial exposures along the wafer perimeter region. In one example embodiment, an exposure system reticle is configured with both a normal area (die yielding area) and a dumification area (non-yielding area at wafer perimeter), thereby allowing for lithographic processing in the non-yielding areas sufficient to facilitate successful processing in the adjacent die yielding areas, but without requiring additional sacrificial exposures. This reduction in sacrificial exposures translates to a significant improvement in fab capacity. The techniques can be implemented, for example, on any number of lithography tools having an adjustable reticle or reticle blind capability and in the context of any technology nodes, such as 95 nm and smaller. The lithography tool may produce wafers at a faster rate.",VARELA ALEJANDRO;;MAXIM MICHAEL A;;VANLARE DANIEL E;;LAZAR ADI,VARELA ALEJANDRO;;MAXIM MICHAEL A;;VANLARE DANIEL E;;LAZAR ADI,INTEL CORPORATION (2011-01-12),https://lens.org/082-437-997-208-58X,Patent Application,yes,6,3,2,2,0,G03B27/42;;G03F1/38;;G03F7/70433;;G03F1/38;;G03B27/42;;G03F7/70433,H01L29/06;;G03B27/42,355/53;;257/620;;X257E29006,0,0,,,,DISCONTINUED
60,CN,A,CN 115667224 A,041-897-976-920-287,2023-01-31,2023,CN 202180030554 A,2021-02-26,US 202062981907 P;;US 2021/0019942 W,2020-02-26,Inhibitors of SCL15A4 small molecules with anti-inflammatory activity,"Small molecule inhibitors of SLC15A4 are disclosed, as well as methods of using the same to treat pDC mediated diseases and disorders.",SCRIPPS RESEARCH INST,LAZAR DANIEL;;JADHAV APASO;;PARKER CHRISTOPHER GEORGE;;TYARO JOHN ROSS,,https://lens.org/041-897-976-920-287,Patent Application,no,0,0,8,8,0,C07D471/04;;C07D235/30;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;A61P29/00;;C07D413/14;;C07D403/12;;A61K31/4184;;A61K31/428;;A61K31/4725;;A61K31/437;;A61P25/00;;A61P29/00;;C07D417/12;;C07D401/12;;C07D471/04;;C07D235/30;;C07D403/14;;C07D405/12;;C07D209/08;;C07D209/86;;C07D235/30;;C07D401/12;;C07D401/14;;C07D403/06;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D471/04,C07D235/30;;A61K31/4168;;A61P29/00;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;C07D413/14;;C07D471/04,,0,0,,,,PENDING
61,KR,A,KR 20220147114 A,076-203-032-421-027,2022-11-02,2022,KR 20227033302 A,2021-02-26,US 202062981907 P;;US 2021/0019942 W,2020-02-26,항-염증 활성을 갖는 SCL15A4의 소분자 억제제들,SLC15A4의 소분자 억제제들 및 pDC-매개된 질환들 및 병태들을 치료하기 위해 이들을 사용하는 방법들이 개시된다.,SCRIPPS RESEARCH INST,LAZAR DANIEL;;JADHAV APPASO;;PARKER CHRISTOPHER GEORGE;;TEIJARO JOHN ROSS,,https://lens.org/076-203-032-421-027,Patent Application,no,0,0,8,8,0,C07D471/04;;C07D235/30;;C07D401/12;;C07D403/12;;C07D403/14;;C07D405/12;;A61P29/00;;C07D413/14;;C07D403/12;;A61K31/4184;;A61K31/428;;A61K31/4725;;A61K31/437;;A61P25/00;;A61P29/00;;C07D417/12;;C07D401/12;;C07D471/04;;C07D235/30;;C07D403/14;;C07D405/12;;C07D209/08;;C07D209/86;;C07D235/30;;C07D401/12;;C07D401/14;;C07D403/06;;C07D403/12;;C07D403/14;;C07D405/12;;C07D405/14;;C07D413/14;;C07D417/12;;C07D471/04,C07D403/12;;A61K31/4184;;A61K31/428;;A61K31/437;;A61K31/4725;;A61P25/00;;A61P29/00;;C07D235/30;;C07D401/12;;C07D417/12;;C07D471/04,,0,0,,,,PENDING
62,US,A1,US 2023/0242627 A1,001-257-179-367-515,2023-08-03,2023,US 202318169127 A,2023-02-14,US 202318169127 A;;US 202016756632 A;;US 2018/0056943 W;;US 201762575307 P,2017-10-20,COMPOSITION AND METHOD FOR ACTIVATING LATENT HUMAN IMMUNODEFICIENCY VIRUS (HIV),"Provided are compositions and methods for activating latent Human Immunodeciency Virus (HIV). The compositions and methods may utilize a recombinant peptide that has a DNA-binding zinc finger domain specific to the HIV LTR sequence. The recombinant peptide may also have a transcription factor (e.g. a transcription activator) that is conjuated to the zinc finger domain. Also provided are methods of treating HIV in a subject in need of the treatment. The method may involve activation of latent HIV in cells of the subject and selectively removing such cells from the subject, providing complete and effective treatment of HIV.",HOPE CITY,MORRIS KEVIN V;;WEINBERG MARC S;;SCOTT TRISTAN;;LAZAR DANIEL,CITY OF HOPE (2017-11-08),https://lens.org/001-257-179-367-515,Patent Application,yes,0,0,4,4,0,A61K38/00;;C07K14/4705;;C07K2319/09;;C07K2319/10;;C07K2319/24;;A61P31/18;;C07K16/10;;C07K14/00,C07K16/10;;C07K14/00,,0,0,,,,PENDING
63,US,A1,US 2024/0061673 A1,118-033-784-745-73X,2024-02-22,2024,US 202318498111 A,2023-10-31,US 202318498111 A;;US 202217839550 A,2022-06-14,File Upload Validation,"Methods, storage systems and computer program products implement embodiments of the present invention that include deploying, to a computer, a hot-patched method for an original method in a method library that is dynamically loaded by a software application running on the computer, wherein the hot-patched method is configured to intercept requests from the software application to the original method. An upload policy can then be specified. Upon the hot-patched method intercepting a request from the software application to the original method to upload a given file from the computer to an Internet site, a comparison can be made between the intercepted request to the policy. In response to the comparison, the upload can be controlled.",SECURITY SAVVY LTD,BEN ZAKAI DAVID;;KLEINER ELDAR;;GUZNER GUY;;HORMAN YOAV;;LAZAR AVISHAI;;PAROLLA DANIEL,SECURITY SAVVY LTD (2023-10-30),https://lens.org/118-033-784-745-73X,Patent Application,yes,0,0,1,3,0,G06F8/65,G06F8/65,,0,0,,,,PENDING
64,PL,A1,PL 192746 A1,155-856-507-977-638,1978-04-10,1978,PL 19274676 A,1976-09-29,PL 19274676 A,1976-09-29,SRODEK ZWILZAJACY,,INST CIEZKIEJ SYNTEZY ORGA,GLOSNICKA MIROSLAWA;;POREDA KAZIMIERZ;;GIBAS JOZEF;;MAKSYMIEC DANIEL;;RICHTER RENATA;;LAZAR ELEONORA;;KOWALSKI JOZEF,,https://lens.org/155-856-507-977-638,Patent Application,no,0,0,2,2,0,,C11D/;;C11D1/72;;D06L/;;D06P/,,0,0,,,,EXPIRED
65,RO,A2,RO 128176 A2,063-749-182-296-930,2013-02-28,2013,RO 201100754 A,2011-07-29,RO 201100754 A,2011-07-29,COMPACT PORTABLE LASER FOR DEDICATED ETCHING APPLICATIONS,"The invention relates to the carrying out of a compact portable laser for dedicated etching applications, with pulse operation regime. According to the invention, the laser consists of a compact laser module with solid active medium pumped with diodes, a system for switching the laser radiation quality, a high reflectivity mirror, a laser radiation output mirror with low reflectivity, a diaphragm, an optical system of laser radiation collimation, a system of laser radiation deflection with polygonal mirror, a laser control system with tactile display, all being integrated in a single unit.",OPTOELECTRONICA 2001 S A,NECSOIU TEODOR;;COMANESCU BRINDUS DANIEL;;SERBANESCU MIHAI;;LAZAR MARIAN;;DMITRI DVORNIKOV;;STANCU RADU FLORIN,,https://lens.org/063-749-182-296-930,Unknown,no,0,0,1,1,0,,H01S5/024;;H01S5/10,,0,0,,,,PENDING
66,US,B2,US 10782039 B2,096-480-013-832-366,2020-09-22,2020,US 201514712019 A,2015-05-14,US 201514712019 A;;US 201562104900 P,2015-01-19,Programmable smart thermostat,"A thermostat includes a front housing, a rear housing interoperably coupled to the front housing, at least one sensor integrated with the front housing, a display integrated with the front housing, and processing circuitry interoperably coupled to the at least one sensor and the display. The display is a touch-screen display and is configured to demonstrate a user-interface screen. The user-interface screen comprises a horseshoe-shaped temperature scale, a heat set-point control, and a cool set-point control. The heat set-point control and the cool set-point control are positioned on the horseshoe-shaped temperature scale. The horseshoe-shaped temperature scale can be adjusted by dragging at least one of the heat set-point control and the cool set-point control along circumferential edges of the horseshoe-shaped temperature scale.",LENNOX IND INC,GOLDEN KYLE;;CASTILLO DANIEL;;MOWERY KEITH;;CHARAVDA JAYPRAKASH;;AMOROS MELISSA;;KHIANI SUNIL K;;LAZAR STEVE,LENNOX INDUSTRIES INC (2015-06-12),https://lens.org/096-480-013-832-366,Granted Patent,yes,96,1,8,30,0,G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G06Q10/20;;H04L67/12;;F24F11/49;;F24F11/58;;F24F11/523;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/58;;F24F11/523;;F24F11/49;;G05B19/042;;G06Q10/20;;H04L12/2809;;H04L67/12,F24F11/30;;F24F11/52;;F24F11/62;;F24F11/89;;F24F120/10;;F24F130/00;;F24F130/10;;G05B19/042;;G06Q10/00;;H04L12/28;;H04L29/08,,12,0,,,"Venstar ColorTouch Thermostats, Innovative Retail Technologies, Venstar Inc., Jun. 13, 2013.;;National Digital Forecast Database, NOAA.;;Energy Efficient Smart Thermostat: Nest, designboom.com [online], published Oct. 26, 2011, [retrieved May 24, 2016], retrieved from the Internet <URL:http://www.designboom.com/technology/energyefficientsmartthermostatnest/>.;;Lennox iComfort S30, contractingbusiness.com [online], published Mar. 13, 2015, [retrieved May 24, 2016], retrieved from the Internet <URL:http://contractingbusiness.com/residential-hvach/tech-update-march-2015-hydronics-home-automation#slide-0-field_images-32371>.;;Nest Smart Thermostat, design-milk.com [online], published Oct. 25, 2011, [retrieved May 24, 2016], retrieved from the Internet <URL:http://design-milk.com/nest-smart-thermostat/>.;;U.S. Appl. No. 14/712,030, Golden et al.;;U.S. Appl. No. 14/711,938, Golden et al.;;U.S. Appl. No. 29/535,235, Golden et al.;;U.S. Appl. No. 29/535,236, Golden et al.;;Innovative Retail Technologies; “Venstar ColorTouch Thermostats Now Feature Real-Time Weather, Remote Firmware Upgrades and Humidity Support”; https://www.innovativeretailtechnologies.com/doc/venstar-colortouch-feature-real-time-weather-remote-firmware-support-0001; Jun. 13, 2013; 4 pages.;;U.S. Appl. No. 15/634,260, Khiani, et al.;;U.S. Appl. No. 16/019,784, Brahme et al.",ACTIVE
67,US,A,US 4107340 A,036-157-679-279-572,1978-08-15,1978,US 81788977 A,1977-07-21,US 68064376 A,1976-04-27,Method of removing corn from the cob,"Whole kernels of corn are removed intact from the cob by a method wherein the cob is first split longitudinally. Then, a force is applied to the kernels to remove them from the cob. The so-separated whole kernels may then be processed in conventional manner.",US AGRICULTURE,ROBERTSON GEORGE H;;LAZAR MELVIN E;;KROCHTA JOHN M;;FARKAS DANIEL F;;BOMBEN JOHN L,,https://lens.org/036-157-679-279-572,Granted Patent,yes,5,1,1,1,0,A23N5/00;;A23N5/00,A23N5/00,426/481,0,0,,,,EXPIRED
68,US,B2,US 9857090 B2,156-386-818-208-492,2018-01-02,2018,US 201514712030 A,2015-05-14,US 201514712030 A;;US 201562104900 P,2015-01-19,Programmable smart thermostat,"A home environment system includes a programmable thermostat and at least one server configured to communicate with the programmable thermostat via a wireless network. The at least one server is configured to receive information regarding work performed on at least one component of an HVAC system, generate a first report regarding the work performed, receive information regarding subsequent work performed on the at least one component of the HVAC system, generate a second report regarding the subsequent work performed, and perform a comparison between the first report and the second report. The at least one server is further configured to generate a comparison report that indicates differences between the first report and the second report and forward the generated comparison report to at least one of the programmable thermostat and at least one communication device.",LENNOX IND INC;;LENNOX IND INC,GOLDEN KYLE;;CASTILLO DANIEL;;MOWERY KEITH;;CHARAVDA JAYPRAKASH;;AMOROS MELISSA;;KHIANI SUNIL K;;LAZAR STEVE,LENNOX INDUSTRIES INC (2015-06-12),https://lens.org/156-386-818-208-492,Granted Patent,yes,71,25,8,30,0,G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G06Q10/20;;H04L67/12;;F24F11/49;;F24F11/58;;F24F11/523;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/58;;F24F11/523;;F24F11/49;;G05B19/042;;G06Q10/20;;H04L12/2809;;H04L67/12,G06F7/00;;F24F11/00;;G05B19/042;;G06Q10/00;;H04L12/28;;H04L29/08,,10,0,,,"U.S. Appl. No. 14/712,019, Golden et al.;;U.S. Appl. No. 14/711,938, Golden et al.;;U.S. Appl. No. 29/535,235, Golden et al.;;U.S. Appl. No. 29/535,236, Golden et al.;;Energy Efficient Smart Thermostat: Nest, designboom.com [online], published Oct. 26, 2011, [retrieved May 24, 2016], retrieved from the Internet <URL:http://www.designboom.com/technology/energyefficientsmartthermostatnest/>.;;Lennox iComfort S30, contractingbusiness.com [online], published Mar. 13, 2015, [retrieved May 24, 2016], retrieved from the Internet <URL:http://contractingbusiness.com/residential-hvac/tech-update-march-2015-hydronics-home-automation#slide-0-field—images-32371>.;;Nest Smart Thermostat, design-milk.com [online], published Oct. 25, 2011, [retrieved May 24, 2016], retrieved from the Internet <URL:http://design-milk.com/nest-smart-thermostat/>.;;Innovative Retail Technologies; “Venstar ColorTouch Thermostats Now Feature Real-Time Weather, Remote Firmware Upgrades and Humidity Support”; https://www.innovativeretailtechnologies.com/doc/venstar-colortouch-feature-real-time-weather-remote-firmware-support-0001; Jun. 13, 2013; 4 pages.;;National Oceanic and Atmospheric Administration (NOAA); “National Digital Forecast Database (NDFD)”; https://www.ncdc.noaa.gov/data-access/model-data/model-datasets/national-digital-forecast-database-ndfd; Nov. 2015; 3 pages.;;U.S. Appl. No. 15/634,260, Khiani, et al.",ACTIVE
69,CA,A1,CA 2912281 A1,105-561-214-909-242,2016-07-19,2016,CA 2912281 A,2015-11-18,US 201562104900 P,2015-01-19,PROGRAMMABLE SMART THERMOSTAT,"A thermostat includes a front housing, a rear housing interoperably coupled to the front housing, at least one sensor integrated with the front housing, a display integrated with the front housing, and processing circuitry interoperably coupled to the at least one sensor and the display. The processing circuitry is configured to periodically activate the at least one sensor, receive data from the at least one sensor and determine, from the received data, whether movement has occurred. Responsive to a determination that the movement has occurred, determine whether the movement is by a human and responsive to a determination that the movement was not by the human, adjust display attributes.",LENNOX IND INC,GOLDEN KYLE;;CASTILLO DANIEL;;MOWERY KEITH;;CHARAVDA JAYPRAKASH;;AMOROS MELISSA;;KHIANI SUNIL K;;LAZAR STEVE,,https://lens.org/105-561-214-909-242,Patent Application,no,0,0,8,30,0,G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G06Q10/20;;H04L67/12;;F24F11/49;;F24F11/58;;F24F11/523;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/58;;F24F11/523;;F24F11/49;;G05B19/042;;G06Q10/20;;H04L12/2809;;H04L67/12,G05D23/19;;F24F11/00,,0,0,,,,DISCONTINUED
70,US,A1,US 2016/0209058 A1,168-552-194-919-531,2016-07-21,2016,US 201514712030 A,2015-05-14,US 201514712030 A;;US 201562104900 P,2015-01-19,PROGRAMMABLE SMART THERMOSTAT,"A home environment system includes a programmable thermostat and at least one server configured to communicate with the programmable thermostat via a wireless network. The at least one server is configured to receive information regarding work performed on at least one component of an HVAC system, generate a first report regarding the work performed, receive information regarding subsequent work performed on the at least one component of the HVAC system, generate a second report regarding the subsequent work performed, and perform a comparison between the first report and the second report. The at least one server is further configured to generate a comparison report that indicates differences between the first report and the second report and forward the generated comparison report to at least one of the programmable thermostat and at least one communication device.",LENNOX IND INC,GOLDEN KYLE;;CASTILLO DANIEL;;MOWERY KEITH;;CHARAVDA JAYPRAKASH;;AMOROS MELISSA;;KHIANI SUNIL K;;LAZAR STEVE,LENNOX INDUSTRIES INC (2015-06-12),https://lens.org/168-552-194-919-531,Patent Application,yes,8,12,8,30,0,G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G06Q10/20;;H04L67/12;;F24F11/49;;F24F11/58;;F24F11/523;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/58;;F24F11/523;;F24F11/49;;G05B19/042;;G06Q10/20;;H04L12/2809;;H04L67/12,F24F11/00;;G05B19/042;;G06Q10/00;;H04L12/28;;H04L29/08,,0,0,,,,ACTIVE
71,US,A1,US 2016/0209071 A1,041-247-134-544-76X,2016-07-21,2016,US 201514712019 A,2015-05-14,US 201514712019 A;;US 201562104900 P,2015-01-19,PROGRAMMABLE SMART THERMOSTAT,"A thermostat includes a front housing, a rear housing interoperably coupled to the front housing, at least one sensor integrated with the front housing, a display integrated with the front housing, and processing circuitry interoperably coupled to the at least one sensor and the display. The display is a touch-screen display and is configured to demonstrate a user-interface screen. The user-interface screen comprises a horseshoe-shaped temperature scale, a heat set-point control, and a cool set-point control. The heat set-point control and the cool set-point control are positioned on the horseshoe-shaped temperature scale. The horseshoe-shaped temperature scale can be adjusted by dragging at least one of the heat set-point control and the cool set-point control along circumferential edges of the horseshoe-shaped temperature scale.",LENNOX IND INC,GOLDEN KYLE;;CASTILLO DANIEL;;MOWERY KEITH;;CHARAVDA JAYPRAKASH;;AMOROS MELISSA;;KHIANI SUNIL K;;LAZAR STEVE,LENNOX INDUSTRIES INC (2015-06-12),https://lens.org/041-247-134-544-76X,Patent Application,yes,30,10,8,30,0,G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G06Q10/20;;H04L67/12;;F24F11/49;;F24F11/58;;F24F11/523;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/58;;F24F11/523;;F24F11/49;;G05B19/042;;G06Q10/20;;H04L12/2809;;H04L67/12,F24F11/00,,2,0,,,"Venstar ColorTouch Thermostats, Innovative Retail Technologies, Venstar Inc., 06/13/2013;;National Digital Forecast Database, NOAA",ACTIVE
72,US,A1,US 2016/0209072 A1,045-522-527-674-791,2016-07-21,2016,US 201514711938 A,2015-05-14,US 201514711938 A;;US 201562104900 P,2015-01-19,PROGRAMMABLE SMART THERMOSTAT,"A thermostat includes a front housing, a rear housing interoperably coupled to the front housing, at least one sensor integrated with the front housing, a display integrated with the front housing, and processing circuitry interoperably coupled to the at least one sensor and the display. The processing circuitry is configured to periodically activate the at least one sensor, receive data from the at least one sensor and determine, from the received data, whether movement has occurred. Responsive to a determination that the movement has occurred, determine whether the movement is by a human and responsive to a determination that the movement was not by the human, adjust display attributes.",LENNOX IND INC,GOLDEN KYLE;;CASTILLO DANIEL;;MOWERY KEITH;;CHARAVDA JAYPRAKASH;;AMOROS MELISSA;;KHIANI SUNIL K;;LAZAR STEVE,LENNOX INDUSTRIES INC (2015-06-12),https://lens.org/045-522-527-674-791,Patent Application,yes,22,112,8,30,0,G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G06Q10/20;;H04L67/12;;F24F11/49;;F24F11/58;;F24F11/523;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/58;;F24F11/523;;F24F11/49;;G05B19/042;;G06Q10/20;;H04L12/2809;;H04L67/12,F24F11/00;;F24F11/02,,1,0,,,"Innovative Retail Technologies - Venstar ColorTouch Thermostat, 06/13/2013",DISCONTINUED
73,US,S,US D0798310 S,094-693-052-094-411,2017-09-26,2017,US 201529535235 F,2015-08-05,US 201529535235 F;;US 201514711938 A;;US 201562104900 P,2015-01-19,Display screen with graphical user interface,,LENNOX IND INC,GOLDEN KYLE;;CASTILLO DANIEL;;MOWERY KEITH;;CHARAVDA JAYPRAKASH;;AMOROS MELISSA;;KHIANI SUNIL K;;LAZAR STEVE,LENNOX INDUSTRIES INC (2015-06-12),https://lens.org/094-693-052-094-411,Design Right,no,0,23,8,30,0,G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G06Q10/20;;H04L67/12;;F24F11/49;;F24F11/58;;F24F11/523;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/58;;F24F11/523;;F24F11/49;;G05B19/042;;G06Q10/20;;H04L12/2809;;H04L67/12,,1404;;D14/485,0,0,,,,ACTIVE
74,US,S,US D0798311 S,013-288-475-737-776,2017-09-26,2017,US 201529535236 F,2015-08-05,US 201529535236 F;;US 201514711938 A;;US 201562104900 P,2015-01-19,Display screen with graphical user interface,,LENNOX IND INC,GOLDEN KYLE;;CASTILLO DANIEL;;MOWERY KEITH;;CHARAVDA JAYPRAKASH;;AMOROS MELISSA;;KHIANI SUNIL K;;LAZAR STEVE,LENNOX INDUSTRIES INC (2015-06-12),https://lens.org/013-288-475-737-776,Design Right,no,0,68,8,30,0,G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G06Q10/20;;H04L67/12;;F24F11/49;;F24F11/58;;F24F11/523;;F24F11/30;;F24F11/89;;F24F11/52;;F24F2120/10;;F24F2130/10;;F24F11/62;;F24F2130/00;;G05B19/0426;;G05B2219/25168;;G05B2219/2614;;H04L12/2827;;H04L2012/285;;F24F11/58;;F24F11/523;;F24F11/49;;G05B19/042;;G06Q10/20;;H04L12/2809;;H04L67/12,,1404;;D14/485,0,0,,,,ACTIVE
75,WO,A1,WO 2019/067877 A1,104-335-992-624-209,2019-04-04,2019,US 2018/0053391 W,2018-09-28,US 201816128499 A;;US 201762566410 P,2017-09-30,"SYSTEM, DEVICES, AND METHODS INCLUDING A SPINAL RESISTANCE ASSEMBLY","Systems, devices, and methods are described for providing, among other things, a neck and spine strengthening device. In an embodiment, the neck strengthening device includes a spinal resistance assembly including at least one resistance component configured to apply a resist force or to resist rotation about a first axis. In an embodiment, the spinal resistance assembly permits lateral neck rotation of a user about the first axis while substantially limiting flexional and extensional movement. In an embodiment, the neck strengthening device includes a device securing assembly configured to physically anchor the device to an anchoring structure. In an embodiment, the neck strengthening device includes a head affixing assembly configured to secure to a head of a user during use. In an embodiment, the strengthening device is instrumented with sensors and an embedded computing system to securely exchange exercise performance and configuration data with local client devices and monitor and record exercise activity and exercise performance data to remote, internet connected serves.",ORTHOPEDIC WELLNESS LABORATORIES INC,WALKER BRAD;;SKIDMORE JOSEPH;;POOLE AARON;;KAHN MICHAEL;;LAZAR DANIEL;;GRAY JERROLD;;SHAH RAJEN;;DÍAZ ROY,,https://lens.org/104-335-992-624-209,Patent Application,yes,9,0,5,7,0,A63B21/16;;A63B23/025;;A63B24/00;;A63B2023/003;;A63B21/4003;;A63B21/4049;;A63B21/4045;;A63B21/22;;A63B21/1627;;A63B2209/10;;A63B21/00192;;A63B21/0051;;A63B21/005;;A63B21/008;;A63B21/02;;A63B21/0414;;A63B2220/10;;A63B2220/34;;A63B2220/808;;A63B2220/805;;A63B2220/89;;A63B2220/16;;A63B2220/801;;A63B2220/51;;A63B2220/56;;A63B24/0062;;A63B71/0622;;A63B2071/0625;;A63B2225/50;;A63B2225/20;;A63B2071/063;;A63B21/169;;A63B2071/0694;;A63B2225/74;;A63B2225/093;;A63B2208/0233;;A63B21/0023,A63B21/16;;A63B23/025;;A63B24/00,,3,2,028-308-142-948-305;;053-152-512-088-102,10.1136/annrheumdis-2014-205327;;24790065;;10.1136/annrheumdis-2013-204428;;24665116,"STORHEIM KZWART JA: ""Musculoskeletal disorders and the global burden of disease study"", ANN RHEUMATIC DIS, vol. 73, 2014, pages 949 - 950;;HOY DMARCH LBROOKS P ET AL.: ""The global burden of low back pain: estimates from the Global Burden of Disease 2010 study"", ANN RHEUM DIS, vol. 73, 2014, pages 968 - 74;;See also references of EP 3687637A4",PENDING
76,US,B1,US 7171911 B1,014-658-915-294-131,2007-02-06,2007,US 78821704 A,2004-02-26,US 78821704 A;;US 45049803 P,2003-02-26,Mobile folding table having a lifting assist center torsion bar and lift off casters,"There is provided an apparatus for a folding table assembly comprising a lifting assist center torsion bar assembly, a lift off caster assembly and a stability locking mechanism. A folding table assembly with a lifting assist mechanism provides a lifting assist force during a portion of the folding process of a foldable table from an unfolded use position to a folded storage position. A lift off caster assembly maintains an unfolded table assembly in a stationary position and prevents the unfolded table from wandering or deviating from its original location on the floor. There is also provided a stability locking mechanism that can set the folding table in a folded and stable semi-closed position.",MIDWEST FOLDING PRODUCTS,RIVERA JR JEREMIAS C;;LAZAR JOHN DANIEL;;SAMIKKANNU DOSS;;ZEEB SCOTT M;;ANTHONY III PHILIP M,MIDWEST FOLDING PRODUCTS (2004-02-24),https://lens.org/014-658-915-294-131,Granted Patent,yes,15,27,3,3,0,A47B3/14;;A47B2003/145;;A47B3/14;;A47B2003/145,A47B3/083,108/169;;108/173;;108/166;;108/115,0,0,,,,INACTIVE
77,US,B2,US 7448330 B2,164-428-568-482-044,2008-11-11,2008,US 69836507 A,2007-01-26,US 69836507 A;;US 78821704 A;;US 45049803 P,2003-02-26,Mobile folding table having a lifting assist center torsion bar and lift off casters,"There is provided an apparatus for a folding table assembly comprising a lifting assist center torsion bar assembly, a lift off caster assembly and a stability locking mechanism. A folding table assembly with a lifting assist mechanism provides a lifting assist force during a portion of the folding process of a foldable table from an unfolded use position to a folded storage position. A lift off caster assembly maintains an unfolded table assembly in a stationary position and prevents the unfolded table from wandering or deviating from its original location on the floor. There is also provided a stability locking mechanism that can set the folding table in a folded and stable semi-closed position.",MIDWEST FOLDING PRODUCTS,RIVERA JR JEREMIAS C;;LAZAR JOHN DANIEL;;SAMIKKANNU DOSS;;ZEEB SCOTT M;;ANTHONY III PHILIP M,,https://lens.org/164-428-568-482-044,Granted Patent,yes,16,2,3,3,0,A47B3/14;;A47B2003/145;;A47B3/14;;A47B2003/145,A47B3/083,108/169;;108/173;;108/166;;108/115,0,0,,,,EXPIRED
78,US,A1,US 2022/0260545 A1,075-119-281-826-959,2022-08-18,2022,US 202217587409 A,2022-01-28,US 202217587409 A;;US 201615013558 A;;US 89196310 A;;US 43925809 A;;US 2008/0070052 W;;US 95983307 P,2007-07-17,Apparatus And Method For Measuring Water Quality In A Water Distribution System,"A system for monitoring water quality in a water meter data collection system having a plurality of metering end points (E) for measuring consumption includes a plurality of chemical biological and environmental sensors (S 1, S 2 ) disposed in a distribution system near or within the distribution end points (A, B), with the sensors (S 1, S 2 ) generating electrical signals through a network (G) that can be processed and communicated with the water meter data to a collection station (D) from the metering end points (E).",BADGER METER INC,MEEUSEN RICHARD A;;GOMEZ GREGORY M;;FABER JAMES DONALD;;WEBB DENNIS J;;ZANDRON DANIEL D;;LAZAR MARK,,https://lens.org/075-119-281-826-959,Patent Application,yes,5,0,9,9,0,G01N35/00871;;G01N33/18;;Y10T436/20;;Y10T436/20;;G01N35/00871;;G01N33/18;;G01F1/56,G01N33/18;;G01F1/56;;G01N35/00,,0,0,,,,PENDING
79,US,A1,US 2010/0105146 A1,063-428-365-385-744,2010-04-29,2010,US 43925808 A,2008-07-15,US 43925808 A;;US 95983307 P;;US 2008/0070052 W,2007-07-17,Apparatus and Method for Measuring Water Quality in a Water Distribution System,"A system for monitoring water quality in a water distribution system having a plurality of metering end points (E) for measuring consumption includes a plurality of chemical biological and environmental sensors (S 1, S 2 ) disposed in a distribution system near or within the distribution end points (A, B), with the sensors (S 1, S 2 ) generating electrical signals through a network (G) that can be processed and communicated to a collection station (D) from the metering end points (E).",MEEUSEN RICHARD A;;GOMEZ GREGORY M;;FABER J DONALD;;WEBB DENNIS J;;ZANDRON DANIEL D;;LAZAR MARK,MEEUSEN RICHARD A;;GOMEZ GREGORY M;;FABER J DONALD;;WEBB DENNIS J;;ZANDRON DANIEL D;;LAZAR MARK,BADGER METER INC (2009-03-19),https://lens.org/063-428-365-385-744,Patent Application,yes,1,13,9,9,0,G01N35/00871;;G01N33/18;;Y10T436/20;;Y10T436/20;;G01N35/00871;;G01N33/18;;G01F1/56,G01N33/00;;G01F1/56,436/127;;422/68.1;;73/861.08,0,0,,,,DISCONTINUED
80,WO,A1,WO 2009/012254 A1,077-039-905-548-700,2009-01-22,2009,US 2008/0070052 W,2008-07-15,US 95983307 P,2007-07-17,APPARATUS AND METHOD FOR MEASURING WATER QUALITY IN A WATER DISTRIBUTION SYSTEM,"A system for monitoring water quality in a water distribution system having a plurality of metering end points (E) for measuring consumption includes a plurality of chemical biological and environmental sensors (Sl, S2) disposed in a distribution system near or within the distribution end points (A, B), with the sensors (Sl, S2) generating electrical signals through a network (G) that can be processed and communicated to a collection station (D) from the metering end points (E).",BADGER METER INC;;MEEUSEN RICHARD A;;GOMEZ GREGORY M;;FABER J DONALD;;WEBB DENNIS J;;ZANDRON DANIEL D;;LAZAR MARK,MEEUSEN RICHARD A;;GOMEZ GREGORY M;;FABER J DONALD;;WEBB DENNIS J;;ZANDRON DANIEL D;;LAZAR MARK,,https://lens.org/077-039-905-548-700,Patent Application,yes,2,13,9,9,0,G01N35/00871;;G01N33/18;;Y10T436/20;;Y10T436/20;;G01N35/00871;;G01N33/18;;G01F1/56,G01N15/06,,0,0,,,,PENDING
81,US,A1,US 2020/0033313 A1,092-758-842-327-058,2020-01-30,2020,US 201916587472 A,2019-09-30,US 201916587472 A;;US 201615013558 A;;US 89196310 A;;US 43925809 A;;US 2008/0070052 W;;US 95983307 P,2007-07-17,Apparatus and Method for Measuring Water Quality in a Water Distribution System,"A water quality monitoring computer system for a water distribution network includes a water distribution network configured to receive water from one or more network sources and distribute the water through the water distribution network to one or more network end points, at least one water quality monitor configured to generate water quality data for a distribution zone of the water quality network that includes a zone water source and one or more zone endpoints, which includes network end points downstream from the zone source, and a zone end point meter associated with each of the zone end points, wherein the zone end point meter monitors water flow exiting the distribution zone. At least two of the end point water meters include one or more water quality sensors and at least two of the end point water meters include different water quality sensor types, and the one water quality monitor aggregates water quality sensor data transmitted from the zone end point water meters to generate the distribution zone water quality data.",BADGER METER INC,MEEUSEN RICHARD A;;GOMEZ GREGORY A;;FABER JAMES DONALD;;WEBB DENNIS J;;ZANDRON DANIEL D;;LAZAR MARK,,https://lens.org/092-758-842-327-058,Patent Application,yes,6,2,9,9,0,G01N35/00871;;G01N33/18;;Y10T436/20;;Y10T436/20;;G01N35/00871;;G01N33/18;;G01F1/56,G01N33/18;;G01F1/56;;G01N35/00,,0,0,,,,PENDING
82,MX,A,MX 2009002603 A,160-731-761-561-365,2009-03-20,2009,MX 2009002603 A,2008-07-15,US 95983307 P;;US 2008/0070052 W,2007-07-17,APPARATUS AND METHOD FOR MEASURING WATER QUALITY IN A WATER DISTRIBUTION SYSTEM.,"A system for monitoring water quality in a water distribution system having a plurality of metering end points (E) for measuring consumption includes a plurality of chemical biological and environmental sensors (Sl, S2) disposed in a distribution system near or within the distribution end points (A, B), with the sensors (Sl, S2) generating electrical signals through a network (G) that can be processed and communicated to a collection station (D) from the metering end points (E).",BADGER METER INC,LAZAR MARK;;MEEUSEN RICHARD A;;GOMEZ GREGORY M;;FABER J DONALD;;WEBB DENNIS J;;ZANDRON DANIEL D,,https://lens.org/160-731-761-561-365,Patent Application,no,0,0,9,9,0,G01N35/00871;;G01N33/18;;Y10T436/20;;Y10T436/20;;G01N35/00871;;G01N33/18;;G01F1/56,G01N15/00,,0,0,,,,ACTIVE
83,CA,C,CA 2662394 C,076-878-843-188-500,2018-09-11,2018,CA 2662394 A,2008-07-15,US 95983307 P;;US 2008/0070052 W,2007-07-17,APPARATUS AND METHOD FOR MEASURING WATER QUALITY IN A WATER DISTRIBUTION SYSTEM,"A system for monitoring water quality in a water distribution system having a plurality of metering end points (E) for measuring consumption includes a plurality of chemical biological and environmental sensors (Sl, S2) disposed in a distribution system near or within the distribution end points (A, B), with the sensors (Sl, S2) generating electrical signals through a network (G) that can be processed and communicated to a collection station (D) from the metering end points (E).",BADGER METER INC,MEEUSEN RICHARD A;;GOMEZ GREGORY M;;FABER J DONALD;;WEBB DENNIS J;;ZANDRON DANIEL D;;LAZAR MARK,,https://lens.org/076-878-843-188-500,Granted Patent,no,0,0,9,9,0,G01N35/00871;;G01N33/18;;Y10T436/20;;Y10T436/20;;G01N35/00871;;G01N33/18;;G01F1/56,G01N33/18;;G01F15/06,,0,0,,,,ACTIVE
84,US,A1,US 2016/0153951 A1,162-445-532-144-627,2016-06-02,2016,US 201615013558 A,2016-02-02,US 201615013558 A;;US 89196310 A;;US 43925809 A;;US 2008/0070052 W;;US 95983307 P,2007-07-17,Apparatus And Method For Measuring Water Quality In A Water Distribution System,"A system for monitoring water quality in a water meter data collection system having a plurality ol metering end points (E) for measuring consumption includes a plurality of chemical biological and environmental sensors (S 1, S 2 ) disposed in a distribution system near or within the distribution end points (A, B), with the sensors (S 1, S 2 ) generating electrical signals through a network (G) that can be processed and communicated with the water meter data to a collection station (D) from the metering end points (E).",BADGER METER INC,MEEUSEN RICHARD A;;GOMEZ GREGORY M;;FABER DONALD J;;WEBB DENNIS J;;ZANDRON DANIEL D;;LAZAR MARK,BADGER METER INC (2016-06-13),https://lens.org/162-445-532-144-627,Patent Application,yes,14,0,9,9,0,G01N35/00871;;G01N33/18;;Y10T436/20;;Y10T436/20;;G01N35/00871;;G01N33/18;;G01F1/56,G01N33/18;;G01F1/56;;G01N35/00,,0,0,,,,DISCONTINUED
85,CA,A1,CA 2662394 A1,030-665-898-531-988,2009-01-22,2009,CA 2662394 A,2008-07-15,US 95983307 P;;US 2008/0070052 W,2007-07-17,APPARATUS AND METHOD FOR MEASURING WATER QUALITY IN A WATER DISTRIBUTION SYSTEM,"A system for monitoring water quality in a water distribution system havi ng a plurality of metering end points (E) for measuring consumption includes a plurality of chemical biological and environmental sensors (Sl, S2) dispo sed in a distribution system near or within the distribution end points (A, B), with the sensors (Sl, S2) generating electrical signals through a networ k (G) that can be processed and communicated to a collection station (D) fro m the metering end points (E).",BADGER METER INC,LAZAR MARK;;FABER J DONALD;;WEBB DENNIS J;;GOMEZ GREGORY M;;ZANDRON DANIEL D;;MEEUSEN RICHARD A,,https://lens.org/030-665-898-531-988,Patent Application,no,0,0,9,9,0,G01N35/00871;;G01N33/18;;Y10T436/20;;Y10T436/20;;G01N35/00871;;G01N33/18;;G01F1/56,G01N15/06,,0,0,,,,ACTIVE
86,US,A1,US 2011/0030482 A1,143-496-132-218-384,2011-02-10,2011,US 89196310 A,2010-09-28,US 89196310 A;;US 43925809 A;;US 2008/0070052 W;;US 95983307 P,2007-07-17,Apparatus and Method for Measuring Water Quality in a Water Meter Data Collection System,"A system for monitoring water quality in a water meter data collection system having a plurality of metering end points (E) for measuring consumption includes a plurality of chemical biological and environmental sensors (S 1 , S 2 ) disposed in a distribution system near or within the distribution end points (A, B), with the sensors (S 1 , S 2 ) generating electrical signals through a network (G) that can be processed and communicated with the water meter data to a collection station (D) from the metering end points (E).",MEEUSEN RICHARD A;;GOMEZ GREGORY M;;FABER DONALD J;;WEBB DENNIS J;;ZANDRON DANIEL D;;LAZAR MARK,MEEUSEN RICHARD A;;GOMEZ GREGORY M;;FABER DONALD J;;WEBB DENNIS J;;ZANDRON DANIEL D;;LAZAR MARK,,https://lens.org/143-496-132-218-384,Patent Application,yes,16,21,9,9,0,G01N35/00871;;G01N33/18;;Y10T436/20;;Y10T436/20;;G01N35/00871;;G01N33/18;;G01F1/56,G01F1/56,73/861.08,0,0,,,,DISCONTINUED
87,EP,A1,EP 3687637 A1,034-425-457-031-630,2020-08-05,2020,EP 18862186 A,2018-09-28,US 201762566410 P;;US 201816128499 A;;US 2018/0053391 W,2017-09-30,"SYSTEM, DEVICES, AND METHODS INCLUDING A SPINAL RESISTANCE ASSEMBLY",,ORTHOPEDIC WELLNESS LABORATORIES INC,WALKER BRAD H;;SKIDMORE JOSEPH E;;POOLE AARON D;;KAHN MICHAEL F;;LAZAR DANIEL A;;GRAY JERROLD L;;SHAH RAJEN N;;DÍAZ ROY P,,https://lens.org/034-425-457-031-630,Patent Application,yes,0,0,5,7,0,A63B21/16;;A63B21/00192;;A63B21/0023;;A63B21/005;;A63B21/0051;;A63B21/008;;A63B21/02;;A63B21/0414;;A63B21/1627;;A63B21/169;;A63B21/22;;A63B21/4003;;A63B21/4045;;A63B21/4049;;A63B23/025;;A63B24/00;;A63B24/0062;;A63B71/0622;;A63B2023/003;;A63B2071/0625;;A63B2071/063;;A63B2071/0694;;A63B2208/0233;;A63B2209/10;;A63B2220/10;;A63B2220/16;;A63B2220/34;;A63B2220/51;;A63B2220/56;;A63B2220/801;;A63B2220/805;;A63B2220/808;;A63B2220/89;;A63B2225/093;;A63B2225/20;;A63B2225/50;;A63B2225/74,A63B23/025;;A63B21/16;;A63B24/00,,0,0,,,,PENDING
88,US,A1,US 2020/0222754 A1,192-538-678-021-604,2020-07-16,2020,US 201816627878 A,2018-09-28,US 201816627878 A;;US 201816128499 A;;US 201762566410 P;;US 2018/0053391 W,2017-09-30,"SYSTEMS, DEVICES, AND METHODS INCLUDING A SPINAL RESISTANCE ASSEMBLY","Systems, devices, and methods are described for providing, among other things, a neck and spine strengthening device. In an embodiment, the neck strengthening device includes a spinal resistance assembly including at least one resistance component configured to apply a resist force or to resist rotation about a first axis. In an embodiment, the spinal resistance assembly permits lateral neck rotation of a user about the first axis while substantially limiting flexional and extensional movement. In an embodiment, the neck strengthening device includes a device securing assembly configured to physically anchor the device to an anchoring structure. In an embodiment, the neck strengthening device includes a head affixing assembly configured to secure to a head of a user during use. In an embodiment, the strengthening device is instrumented with sensors and an embedded computing system to securely exchange exercise performance and configuration data with local client devices and monitor and record exercise activity and exercise performance data to remote, internet connected serves.",ORTHOPEDIC WELLNESS LABORATORIES INC,WALKER BRAD H;;SKIDMORE JOSEPH E;;POOLE AARON D;;KAHN MICHAEL F;;LAZAR DANIEL A;;GRAY JERROLD L;;SHAH RAJEN N;;DIAZ ROY P,ORTHOPEDIC WELLNESS LABORATORIES INC (2017-01-12),https://lens.org/192-538-678-021-604,Patent Application,yes,8,6,2,7,0,A63B21/00192;;A63B21/005;;A63B21/008;;A63B21/0085;;A63B21/1627;;A63B23/025;;A63B24/0087;;A63B71/0622;;A63B2220/13;;A63B2220/40;;A63B2220/803;;A63B2220/808;;A63B2220/51;;A63B21/4033;;A63B21/4049;;A63B2220/836;;A63B23/0494;;A63B2220/16;;A63B2071/0072;;A63B2225/20;;A63B23/12;;A63B21/4039;;A63B2220/62;;A63B2220/30;;A63B2220/805;;A63B2225/50;;A63B23/0482;;A63B2225/055;;A63B2071/0688;;A63B2071/0625;;A63B23/025;;A63B24/0087;;A63B21/008;;A63B21/0085;;A63B21/005;;A63B2220/808;;A63B71/0622;;A63B21/1627;;A63B2220/13;;A63B2220/803;;A63B2220/40;;A63B21/00192,A63B23/025;;A63B21/00;;A63B21/005;;A63B21/008;;A63B21/16;;A63B24/00;;A63B71/06,,0,0,,,,ACTIVE
89,US,B2,US 11020631 B2,033-572-900-540-362,2021-06-01,2021,US 201816627878 A,2018-09-28,US 201816627878 A;;US 201816128499 A;;US 201762566410 P;;US 2018/0053391 W,2017-09-30,"Systems, devices, and methods including a spinal resistance assembly","Systems, devices, and methods are described for providing, among other things, a neck and spine strengthening device. The strengthening device includes a spinal resistance assembly configured to apply a resist force or to resist rotation about at least a first axis, and a head affixing assembly configured to secure to a head of a user during use. The strengthening device is instrumented with sensors and an embedded computing system configured to securely exchange exercise performance and configuration data with local client devices, and to monitor and record exercise activity and exercise performance data.",ORTHOPEDIC WELLNESS LABORATORIES INC,WALKER BRAD H;;SKIDMORE JOSEPH E;;POOLE AARON D;;KAHN MICHAEL F;;LAZAR DANIEL A;;GRAY JERROLD L;;SHAH RAJEN N;;DIAZ ROY P,ORTHOPEDIC WELLNESS LABORATORIES INC (2017-01-12),https://lens.org/033-572-900-540-362,Granted Patent,yes,9,4,2,7,0,A63B21/00192;;A63B21/005;;A63B21/008;;A63B21/0085;;A63B21/1627;;A63B23/025;;A63B24/0087;;A63B71/0622;;A63B2220/13;;A63B2220/40;;A63B2220/803;;A63B2220/808;;A63B2220/51;;A63B21/4033;;A63B21/4049;;A63B2220/836;;A63B23/0494;;A63B2220/16;;A63B2071/0072;;A63B2225/20;;A63B23/12;;A63B21/4039;;A63B2220/62;;A63B2220/30;;A63B2220/805;;A63B2225/50;;A63B23/0482;;A63B2225/055;;A63B2071/0688;;A63B2071/0625;;A63B23/025;;A63B24/0087;;A63B21/008;;A63B21/0085;;A63B21/005;;A63B2220/808;;A63B71/0622;;A63B21/1627;;A63B2220/13;;A63B2220/803;;A63B2220/40;;A63B21/00192,A63B23/025;;A63B21/00;;A63B21/005;;A63B21/008;;A63B21/16;;A63B24/00;;A63B71/06,,0,0,,,,ACTIVE
90,EP,A4,EP 3687637 A4,046-326-193-946-838,2021-06-16,2021,EP 18862186 A,2018-09-28,US 201762566410 P;;US 201816128499 A;;US 2018/0053391 W,2017-09-30,"SYSTEM, DEVICES, AND METHODS INCLUDING A SPINAL RESISTANCE ASSEMBLY",,ORTHOPEDIC WELLNESS LABORATORIES INC,WALKER BRAD H;;SKIDMORE JOSEPH E;;POOLE AARON D;;KAHN MICHAEL F;;LAZAR DANIEL A;;GRAY JERROLD L;;SHAH RAJEN N;;DÍAZ ROY P,,https://lens.org/046-326-193-946-838,Search Report,no,3,0,5,7,0,A63B21/16;;A63B23/025;;A63B24/00;;A63B2023/003;;A63B21/4003;;A63B21/4049;;A63B21/4045;;A63B21/22;;A63B21/1627;;A63B2209/10;;A63B21/00192;;A63B21/0051;;A63B21/005;;A63B21/008;;A63B21/02;;A63B21/0414;;A63B2220/10;;A63B2220/34;;A63B2220/808;;A63B2220/805;;A63B2220/89;;A63B2220/16;;A63B2220/801;;A63B2220/51;;A63B2220/56;;A63B24/0062;;A63B71/0622;;A63B2071/0625;;A63B2225/50;;A63B2225/20;;A63B2071/063;;A63B21/169;;A63B2071/0694;;A63B2225/74;;A63B2225/093;;A63B2208/0233;;A63B21/0023,A63B23/025;;A63B21/00;;A63B21/002;;A63B21/005;;A63B21/008;;A63B21/02;;A63B21/04;;A63B21/16;;A63B21/22;;A63B23/00;;A63B24/00;;A63B71/06,,1,0,,,See also references of WO 2019067877A1,PENDING
91,CA,A1,CA 3077043 A1,050-849-349-664-632,2019-04-04,2019,CA 3077043 A,2018-09-28,US 201762566410 P;;US 201816128499 A;;US 2018/0053391 W,2017-09-30,"SYSTEM, DEVICES, AND METHODS INCLUDING A SPINAL RESISTANCE ASSEMBLY","Systems, devices, and methods are described for providing, among other things, a neck and spine strengthening device. In an embodiment, the neck strengthening device includes a spinal resistance assembly including at least one resistance component configured to apply a resist force or to resist rotation about a first axis. In an embodiment, the spinal resistance assembly permits lateral neck rotation of a user about the first axis while substantially limiting flexional and extensional movement. In an embodiment, the neck strengthening device includes a device securing assembly configured to physically anchor the device to an anchoring structure. In an embodiment, the neck strengthening device includes a head affixing assembly configured to secure to a head of a user during use. In an embodiment, the strengthening device is instrumented with sensors and an embedded computing system to securely exchange exercise performance and configuration data with local client devices and monitor and record exercise activity and exercise performance data to remote, internet connected serves.",ORTHOPEDIC WELLNESS LABORATORIES INC,WALKER BRAD H;;SKIDMORE JOSEPH E;;POOLE AARON D;;KAHN MICHAEL F;;LAZAR DANIEL A;;GRAY JERROLD L;;SHAH RAJEN N;;DIAZ ROY P,,https://lens.org/050-849-349-664-632,Patent Application,no,0,0,5,7,0,A63B21/16;;A63B23/025;;A63B24/00;;A63B2023/003;;A63B21/4003;;A63B21/4049;;A63B21/4045;;A63B21/22;;A63B21/1627;;A63B2209/10;;A63B21/00192;;A63B21/0051;;A63B21/005;;A63B21/008;;A63B21/02;;A63B21/0414;;A63B2220/10;;A63B2220/34;;A63B2220/808;;A63B2220/805;;A63B2220/89;;A63B2220/16;;A63B2220/801;;A63B2220/51;;A63B2220/56;;A63B24/0062;;A63B71/0622;;A63B2071/0625;;A63B2225/50;;A63B2225/20;;A63B2071/063;;A63B21/169;;A63B2071/0694;;A63B2225/74;;A63B2225/093;;A63B2208/0233;;A63B21/0023,A63B23/025;;A63B21/16;;A63B24/00,,0,0,,,,PENDING
